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Mutant huntingtin protein (mhtt)–the protein responsible for cellular 
dysfunction in Huntington’s disease (HD) –is a product of an expanded 
trinucleotide repeat (TNR) cytosine-adenine-guanine (CAG) sequence in exon 1 
of the huntingtin (HTT) gene.  The pathology of HD has been extensively 
researched; however, the mechanism by which the disease-causing TNR 
expansions occur in somatic cells remains elusive.  Interestingly, HD has often 
been referred to a ‘DNA repair disease’, even though DNA repair dysfunction in 
situ has not been identified.  We hypothesized that presence of the mhtt protein 
affects the expression of DNA repair genes used to address DNA repair, ultimately 
affecting genome stability, thus providing a possible mechanism for TRN instability.  
Using quantitative polymerase chain reaction (qPCR) gene arrays for 84 DNA 
repair genes, we identified 18 DNA repair genes with decreased fold changes 
between 2- and 3- fold, as well as 11 genes down regulated greater than 3- fold in 
one HD fibroblast sample relative to a wild-type sample.  To ensure our results 
were not limited to the samples tested, we then increased our number of HD 
samples and investigated gene expression of APEX1, BRCA1, RPA1, and RPA3 
using sensitive TaqMan Gene Expression assays.  Further, immunocytochemistry 
(ICC) analysis validated expression deficiencies at the protein level.  These data 
identify down-regulated genes necessary to maintain stability in the genome of 
multiple HD affected fibroblast lines.  Our data infers that the presence of the toxic 
mutant huntingtin (mHtt) protein is involved in the DNA repair gene inhibition.   
 
 
The mutant huntingtin protein (mHtt) produced in HD exhibits a partial gain-
of-function in that the hydrophobic, expanded polyglutamine region at the N-termini 
aggregates to unintended targets, such as transcription factors and histone 
modifiers.  To identify the broad pathway regulating gene expression down-
regulation, we investigated epigenetic regulatory mechanisms.  Rapid revival of 
selected DNA repair expression was observed in response to pharmacological 
hypomethylation treatment, but not to histone modification treatments.  This 
identifies differential methylation patterns occur as a result of mHtt presence.  
Using capillary electrophoresis fragment analysis to characterize HTT TNR gene 
expansions, our data reveals that intermittent 5-azacytidine treatments induced 
HTT gene stability over 4 population doublings, elucidating methylation patterning 
involvement in TNR instability.   
Furthermore, induced pluripotent stem cells (iPSCs) undergo global 
epigenetic changes relative to its native cell type that include methylation 
patterning changes.  Upon reprogramming of HD-affected fibroblasts into a 
pluripotent state we revealed that gene expression was recovered to wild-type 
levels and was maintained through 20 population doublings.  As well, iPSC-HD 
lines show contraction-biased instability, opposite to expansion-biased instability 
in native fibroblast cell types.  Differentiation of iPSC-HD lines into mesenchymal-
like cells (MLCs) further revealed that APEX1 expression remained static, while 
others retreated to pre-iPSC expression levels.  Interestingly, HD-iPSC derived 
MLCs showed that TNR regions maintained stability in the HTT gene pathogenic 
region, showing no changes in (CAG) repeats.  These findings demonstrate that 
DNA repair gene expression in HD fibroblasts is altered, thus providing insight into 
the mechanism in which TNR instability persists, ultimately leading to genetic 
anticipation.  This also identifies possible biomarkers that can be used to monitor 
disease progression and therapeutic treatment success.  This study also provides 
evidence that TNR instability is pharmacologically alterable.  This is the first 
evidence that a DNA repair gene deficiency is present in cells affected by 
Huntington’s disease.    More so, our data suggests that mechanisms involved in 
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Huntington's disease (HD) is a rare, neurodegenerative disease that affects 
1 in every 30,000 people in the United States.  Phenotypic expression of HD is the 
result of cellular dysfunction, leading to the eventual degeneration of medium spiny 
neurons of the basal ganglia (Gonitel et al., 2008; Swami et al., 2009).  Through 
the degeneration of striatal neurons in the basal ganglia, affected individuals 
progressively experience cognitive, emotional and movement impairments 
(Peyser and Folstein, 1990; Pla et al., 2014).  In about 70% of affected individual’s 
onset of symptoms varies based of the size of the TNR expansion within the 
huntingtin (HTT) gene.  HD is an autosomal-dominant inherited disease, with 
individuals who inherit HD generally not presenting with symptoms until the ages 
of 30 to 50, often after having children of their own.   
The first accurate medical description on HD was made in 1872, by an 
American doctor named George Huntington.  Prior to his accurate description, HD 
was referred to as chorea, describing the involuntary dancing propensities of 
affected individuals.  Later, this definition would be expanded to include jerky 
involuntary movements of the hips, face, and shoulders.  Clinically, this term is still 
predominately used when describing the “dance-like” movements created by 
patients affected by neurological disorders.  Dr. Huntington’s unreferenced paper 
called On Chorea, was initially published in Medical and Surgical Reporter of 
Philadelphia in 1872.  His report addressed and highlighted three main 
peculiarities.  He reported that (1) the disease is hereditary, (2) that affected 
individuals have suicidal and cognition impairments, and (3) that it manifests only 
in adult life (Huntington, 2003).  He hypothesized that chorea, and HD by  
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extension, was the result of derangement of the cerebellum, only knowing at that 
time the involvement of the cerebellum in governing and controlling motor control.  
After the discovery of the HD-causing gene in 1993, it seemed that a cure would 
be just around the corner.  Twenty-two years later, there is still no cure for HD.  At 
best, pharmacological intervention is initiated upon symptom presentation to 
alleviate depression and chorea, but is eventually abandoned as the disease 
progresses and symptoms become unmanageable (Holl et al., 2010; Ondo et al., 
2002; Reilmann, 2013; Reilmann et al., 2015; Sagredo et al., 2012; Yavuz et al., 
2013).  Some research is focusing their efforts toward inhibiting expression of the 
affected allele, utilizing gene silencing technologies such RNA interference 
(Cambon and Deglon, 2013; Lombardi et al., 2009; van Bilsen et al., 2008; Watson 
and Wood, 2012; Zhang et al., 2009).  Multiple studies have shown that silencing 
of the pathogenic mutant huntingtin (mHTT) gene restores normal function, and 
HD-aggregate inclusions disappear (Yamamoto et al., 2000).  At the present time, 
the most promising treatment is cell replacement therapies.  Using animal models, 
replacement of striatal tissue with fetal striatal neural cells has been successful, 
promoting recovery (Kendall et al., 1998; Palfi et al., 1998).  With the recent 
discovery of reprogramming patient derived, terminally differentiated cells into 
induced pluripotent stem cells (iPSCs), much attention is focusing on cellular 
replacement using patient-specific cells (Benraiss and Goldman, 2011; Choi et al., 
2014; Crane et al., 2014; Fink et al., 2014; Yu et al., 2007). 
A novel characteristic of HD is the genetic anticipation experienced by 
successive generations who inherit the mutated allele (Langbehn et al., 2004; 
Langbehn et al., 2010; Ranen et al., 1995).  Genetic anticipation is the phenomena 
by which a diseases’ symptoms manifest earlier and more severely in progeny who 
successively inherit the disease, relative to the affected transmitting parent (Rieger 
et al., 1991).  While this phenomena is primarily associated with neurological and 
TNR disorders, it has also been reported in other diseases and disorders such as 
Lynch syndrome, breast cancer, autism, type 2 diabetes mellitus and Graves’ 
disease (Brix et al., 2003; Martinez-Delgado et al., 2011; Peixoto et al., 2006; Rai 
and Sharif, 2014; Segui et al., 2013; Stupart et al., 2014; Westphalen et al., 2005; 
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Yaturu et al., 2005).  In relation to HD, it is well established that the severity of oms 
is linearly correlated, with age-at-onset (AAO) experienced being inversely 
correlated to the size of the (CAG) TNR expansion in the HTT gene (Penney et al., 
1997; Wexler et al., 2004) (Fig. 1).  It has been shown that increased expansions 
in successive generation’s correlates with more severe symptomatic expression 
and earlier age of onset in > 70% of individuals affected by HD (Lee et al., 2012; 
Walker, 2007).  Interestingly data also reveals that paternal vs maternal 
transmission of the affected allele contributes significantly to TNR length of 
offspring, with paternal transmission generating larger expansions in offspring 
(Ranen et al., 1995).  Furthermore, data suggests that age of transmission does 
not affect (CAG) inheritance, but (CAG) repeat length changes are influenced by 
the paternal (CAG) TNR length (Wheeler et al., 2007).  Conversely, the same study 
determined that there was greater mean (CAG) variability between affected 
siblings when the disease was transmitted maternally.  Studies reveal that 
relatively larger expansions of the pathogenic HTT gene are often present in 
progeny upon HD inheritance (Ranen et al., 1995; Swami et al., 2009; Wheeler et 
al., 2007), with the largest rate of expansion occurring early in the disease course 
(Kennedy et al., 2003).   
HD is a dynamic mutation disease, where the number of the pathogenic 
(CAG) repeats increases the probability of expression of the mutant phenotype.  
People with fewer than 35 (CAG) repeats are usually not affected by the disease, 
or symptoms present late in life.  Individuals with 35 to 40 repeats are at an 
increased risk of developing HD.  Expansions greater than 40 repeats inevitably 
lead to HD progression (Bates, 2003).   
Symptomatic manifestation of HD is the result of neurodegeneration of 
striatal neurons in the basal ganglia, specifically medium spiny neurons (MSNs).  
The basal ganglia is a complex subcortical region in the base of the forebrain.  This 
portion of the brain is a collection of subcortical nuclei that exhibits inhibitory and 
excitatory output, being involved in multiple process, such as voluntary movement, 
cognition, and emotion.  Anatomically, the basal ganglia is comprised of the 









(CAG) Repeat Length 
56 58 
Fig. 1.  Box plot of age of onset and repeat length of the longer HTT allele.  
Huntington’s disease exhibits genetic anticipation, in which affected individuals 
present with clinical symptoms earlier in life inversely related to the length of the 
(CAG) expansion in the HTT gene.  Figure taken from (Wexler, 2004).  Copyright 
(2004) National Academy of Sciences, U.S.A.  
 
 















nucleus, and nigra substantia.  Functionally, the basal ganglia serves as a 
“switchboard” in which input is properly routed and regulated.  It is this region of 
the brain that is predominantly affected by HD, and because of its’ extensive 
involvement in coordinated motor control, the degeneration of the basal ganglia 
causes symptomatic chorea and cognition impairment.   
 
Wild-type and mutant huntingtin protein 
The huntingtin (HTT) gene is located on chromosome 4p16 (Fig. 2).  The 
gene encodes 67 exons producing the huntingtin (Htt) protein, which is ~350kDa 
(Reiner et al., 2011).  The huntingtin protein is ubiquitously expressed throughout 
tissues types, and is essential for embryonic development, with the most prevalent 
expression in neuronal tissues (DiFiglia et al., 1995; Duyao et al., 1995; Ferrante 
et al., 1997; Fusco et al., 1999; Landwehrmeyer et al., 1995; Nasir et al., 1995; 
Trottier et al., 1995; Velier et al., 1998; Zeitlin et al., 1995).  The human HTT gene 
contains trinucleotide repeats (TNR) of cytosine-adenine-guanine (CAG), the 
codon that encodes the amino acid glutamine.  Repetitive repeats of DNA 
sequences are prone to instability, as witnessed in HD.  The disease causing 
variable region of the protein is located at the N-termini in exon 1.  Unaffected 
individuals have (CAG) repeats between 6 and 35.  There are some case where 
patients with 27 – 35 (CAG) repeats have symptoms manifest with reduced 
penetrance late in life.  Individuals with (CAG) repeats > 36 create a mutant 
huntingtin (mHtt) protein, and will eventually develop symptoms.   
The poly-glutamine (polyQ) amino acid chain in the mutant protein product 
is known to be responsible for disease manifestation.  Due to this characteristic, 
HD is categorized as a polyglutamine disease.  At the present time, nine 
polyglutamine diseases have been identified.  The polyglutamine diseases are 
Huntington’s disease, Dentatorubropallidoluysian atrophy, Spinal and bulbar 
muscular atrophy, and Spinocerebellar ataxia types 1, 2, 3 (Joseph Machado 
disease), 6, 7, and 17 (Devys et al., 2001; Masino and Pastore, 2002; Orr, 2001; 
Saudou et al., 1996; Zoghbi and Orr, 2000).  The aggregate-prone protein products 






Fig. 2.  Location of HTT gene in the genome.  The huntingtin gene is located 
near the telomeric region of the p-arm (short) of chromosome, indicated by the 




as the spinal cord, midbrain, and cerebellum (Zoghbi and Orr, 1999).  The 
underlying cause of these diseases is similar in pathogenesis, leading to similar, 
but not identical, symptomatic presentation and progression.  Unfortunately, at 
present time, there is no cure for diseases in this classification, which emphasizes 
the necessity for continued research.   
The structure of the entire Htt protein remains unsolved.  Interestingly, this 
is primarily due not only to its large size, but also due to the pathogenic polyQ 
region in the N-termini.  It has recently been discovered that the polyQ region in 
Htt proteins have “conformational flexibility”.  In other words, the polyQ regions will 
change its structure, indicated by the Htt17Q trimer structure that has been 
resolved (Fig. 3) (Kim et al., 2009). In the HTT gene, the 3’ side of the pathogenic 
TNR region is immediately flanked by (CCG)’s repeats, encoding a polyproline 
(polyP) region.  Interestingly, the presence of the polyP region has been shown to 
decrease the aggregation potential of disease-causing polyQ regions 
(Bhattacharyya et al., 2006; Dehay and Bertolotti, 2006).  Though not fully 
understood, the absence of the polyP sequence enhances mHtt aggregation.  
Currently, the three proposed mechanisms addressing polyP region involvement 
with differential aggregation characteristics are; (1) the presence of the polyP 
region alters the protein conformation, reducing spatial availability for increased 
aggregation, (2) the polyP sequence recruits interactors that shield the toxic effects 
of mHtt, or (3) the polyP residues may solubilize the polyQ region, assisting in its’ 
stability (Steffan et al., 2004) (Fig. 4).  This evidence further complicates HD, as 
well wild-type patients with large repeats that do not yet constitute HD.  It could be 
hypothesized that the absence of the polyP sequence in a wild-type patient, with 
(CAG) repeats < 35, could enhance Htt aggregation, which would initiate 
symptomatic progression.   
Downstream of the polyQ and polyP regions of the protein lie multiple 
consensus sequences called huntingtin, elongation factor3, protein phosphatase 
2A, and TOR 1 (HEAT) domains.  These HEAT domains facilitate protein-protein 
interactions (Li et al., 2006; Takano and Gusella, 2002).  It has also been shown 
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that Htt contains conserved amino acid sequences that target it for nuclear export 
and localization (Bessert et al., 1995; Maiuri et al., 2013; Trottier et al., 1995; Xia 
et al., 2003; Zheng et al., 2013).  It has also been reported that polyQ expansions 
impair the nuclear export and localization properties (Cornett et al., 2005).  These 
data together reveal the important role of Htt, and its’ ability to chaperone proteins 
thorough the nuclear envelope.  As well, it is worth emphasizing that the presence 
of expanded polyQ regions impair mHtt exportation, thus localizing the toxic mHtt 
protein within the nucleus.  Furthermore, data shows that caspase activity on mHtt 
results in cleavage of the toxic polyQ-containing N-termini (Li and Li, 2004).  This 
cleavage results in uninhibited aggregate formation, further compromising cellular 
integrity.   
The exact function of wild-type Htt is unknown, but has been shown to be 
essential for embryonic development, as well as involved in neurotransmission, 
mitotic spindle formation, apoptosis, and axonal transport (Godin et al., 2010; 
Goehler et al., 2004; Harjes and Wanker, 2003; Horn et al., 2006; Saudou et al., 
1998; Waelter et al., 2001).  The expanded polyQ region of mHtt exhibits a toxic, 
partial gain-of-function.  This is evident in the fact that silencing or inactivation of 
the mHtt gradually allows neuronal recovery (van Bilsen et al., 2008; Yamamoto 
et al., 2000; Zhang et al., 2009).  Importantly, there is data suggesting that the loss 
of wild-type Htt function can sensitize neuronal cells, amplifying the toxic effects of 
mHtt present (Cattaneo et al., 2005; Zuccato and Cattaneo, 2007; Zuccato and 
Cattaneo, 2009).  It is evident that disease progression in HD is from the 














Fig. 3.  Resolved structure of the N-termini Htt17Q-trimer.  The trimer above 
represents the conformational flexibility of polyQ sequences.  The green and 
orange segments between structures are polyQ regions, followed by the polyP 
regions indicated by the abbreviation “PP1, PP2”.   Figure taken from (Kim et 
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With the discovery that polyQ residues form polar zipper structures, insight 
was gained that Htt function involved binding of transcription factors that also 
contained polyQ sequences.  Both the wild-type and mutated form of Htt can 
interact with transcription factors.  One of the first molecular observation in HD was 
the differentially down-regulation of neurotransmitter genes, specifically 
enkephalin and substance P mRNA (Augood et al., 1996).  This finding was 
followed up with similar gene expression investigations, leading to the hypothesis 
that mHtt was affecting gene transcription.  Throughout the course of HD research, 
it has been confirmed that mHtt aggregation of unintended targets, combined with 
decreases in Htt presence, causing differential gene down-regulation, cell toxicity, 
dysfunctional neurotransmission and cellular dysfunction (Lipinski and Yuan, 
2004; Nucifora et al., 2001; Shimohata et al., 2000a; Shimohata et al., 2000b).  
Even currently, researchers are still elucidating the severity of gene dysregulation 
in HD.   
One of the most researched gene dysregulations caused by mHtt is that of 
brain derived neurotrophic factor (BDNF).  BDNF is a protein that supports the 
survival of existing neurons and facilitates in the differentiation of neuronal cells, 
as well as being involved in the formation of newly formed synapses (Acheson et 
al., 1995; Huang and Reichardt, 2001).  The interference on BDNF normal 
regulation and function is two-fold in the presence of mHtt.  First, wild-type Htt 
seems to be a regulator of BDNF, and the presence of mHtt showed decreased 
gene expression (Zuccato et al., 2001).  Secondly, decreased levels of Htt reduces 
the huntingtin-mediated transport of the BDNF protein along microtubules 
(Gauthier et al., 2004).  This is an example of just one dysfunction gene affected 
by mHtt.  These two data alone address the extensive repercussions of the 
presence of mHtt (Fig. 5).   
The presence of the expanded mHtt also inhibits efficiency of normal 
neurotransmitter endocytosis.  The wild-type Htt protein forms a complex with 
huntingtin interacting protein 1 (Hip1), adaptor-related protein complex-2 mu-1 
subunit (AP2), and clathrin (CLTA) which is involved in receptor-mediated 
endocytosis (Singaraja et al., 2002; Waelter et al., 2001).  Reductions in the Htt, 
12 
 
decrease the availability to required machinery to maintain appropriate synaptic 
transmission.  Also, the presence of mHtt increases the degradation of AP2 
subunits involved in the endocytosis complex (Borgonovo et al., 2013).  Exocytosis 
is also impaired with the presence of mHtt through the depletion of complex II 
(CPLX2), as well as through the interaction of β-tubulin (TUBB) (Edwardson et al., 
2003; Smith et al., 2009). 
Furthermore, Htt has been linked to apoptotic regulation.  It has been shown 
that defects in calcium (Ca2+) regulation is a hallmark in HD.  mHtt sensitizes 
inositol 1,4,5-trisphosphate receptor, type 1 (ITPR1) and also stimulates N-methyl-
D-aspartate receptor subunit NR1 (NMDAR1), both of which increase Ca2+ levels 
in the cytoplasm and mitochondria (Ciammola et al., 2006; Evert et al., 2000; Li et 
al., 2000; Liu, 1998; Raymond et al., 2011; Rigamonti et al., 2000; Suzuki et al., 
2012).  This accumulation of Ca2+ within the mitochondria initiates the release of 
caspase cofactors inducing apoptosis.  The involvement of mHtt on the 
mitochondrial also increases oxidative stress exhibited by HD patients.  Post-
mortem analysis of HD brains reveals elevated levels of lactate, inferring two 
possible causes (Jenkins et al., 1993; Koroshetz et al., 1997).  The first possibility 
would implicate that oxygen delivery is inadequate, slowing mitochondrial 
metabolism resulting in anaerobic respiration.  The second possible cause would 
involve some disorder resulting in increased carbohydrate metabolism where lactic 
acid formation is favored.  Further, some studies in HD- affected mouse models 
have shown activity decreases in mitochondria complex I, while other complex 
activity remained unchanged (Parker et al., 1990).  Human studies show 
decreased activity in complex II and complex III, with no changes in complex I and 
IV (Butterworth et al., 1985; Mann et al., 1990).  Even though the mechanism by 
which mHtt is altering the activity of mitochondrial function, it is evident that the 
abnormal protein interactions lead to an increase in oxidative stress, resulting in 
neuronal cell death.   
One of the most researched pathogenic consequences of the mHtt protein 
is the abnormal aggregation patterns seen with transcriptional factors that are 
required for basal transcription initiation.  mRNA expression abnormalities are 
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shown to arise in part because mHtt products hijack and aggregate important 
transcriptional regulators and histone acetyl transferases including nuclear protein 
p53, cyclic AMP-response element (CRE)-binding protein (CREB), specific 
protein-1 (Sp1), CREB-binding protein (CREB-BP/CBP),  TATA-box-binding 
protein (TBP), and TATA binding protein (TBP)-associated factor (TAFII130) (Cha, 
2007; Gil and Rego, 2008; Jiang et al., 2006; McCampbell and Fischbeck, 2001).  
Importantly, this aggregation causes vital deficiencies in HD.  This transcriptional 
inhibition causes decreased expression of a myriad of genes (Dunah et al., 2002; 
Lipinski and Yuan, 2004; Shimohata et al., 2000a).  Interestingly, these 
transcriptional regulators have been shown to contain polyQ amino acid 
sequences, for protein-DNA interactions.  It is these binding domains that are 
inadvertently targeted by mHtt.  This unintended aggregation disrupts normal gene 
transcription and is ultimately responsible for some differential gene expression 
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Trinucleotide repeat instability 
As mentioned earlier, a key hallmark of HD is the genetic anticipation 
experienced.  Through the expansion of the pathogenic TNR region of the HTT 
gene during transmission, affected individuals experience increased severity of 
symptoms, while progression occurs earlier in life (Aziz et al., 2012; Langbehn et 
al., 2004; Langbehn et al., 2010; Norremolle et al., 1995; Ranen et al., 1995; 
Swami et al., 2009).  The cause of genetic anticipation comes from the likelihood 
that the tandem repeats in the HTT gene will expand.  Trinucleotide repeat 
instability is the propensity for a dynamic mutation of repetitive bases in the 
genome to increase or decrease in size with a probability that either will cause 
phenotypic changes.  Fundamentally, this is the pathogenic basis for the HD.  
Diseases prone to TNR instability are referred to as trinucleotide repeat disorders, 
and include polyglutamine and non-polyglutamine diseases, with more than half 
being polyglutamine in pathogenetic in origin.  The first of these diseases to be 
identified was Fragile X syndrome.  The diseases characterized by TNR instability 
have pathogenic tandem repeats ranging from 21 for Spinocerebellar ataxia type 
6, to more than 250 in HD (Table 1).   
Aside from germ line inheritance and transmission, the (CAG) repeat in HD 
exhibits somatic instability and undergoes progressive expansion.  This 
characteristic further complicates the identification of the comprehensive model 
underlying HD.  Tissue specific somatic (CAG) instability is present throughout, 
with the gene showing moderate instability in the liver and kidney, and low 
instability muscle and heart tissue (Telenius et al., 1994).  Interestingly, the 
greatest expansions are seen in the testis and brain (De Rooij et al., 1995; Telenius 
et al., 1994).  This mosaicism seen in tissues has been linked to new HD mutations 
arising from previously “unaffected” patients initially exhibiting  (CAG) repeats of 
33 and 35, ultimately expanding to 45 repeats (Cannella et al., 2005).  It is worth 
noting that HTT mosaicism in the brain has been linked to an earlier age of onset, 
but it is not known how this affects pathogenesis (Reiner et al., 2011). To confound 
the disease further, researchers must first identify if tissue specific (CAG) repeat 
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instability is the result of the same mechanism, or if different mechanisms in 































Table 1   
Trinucleotide repeat disorders and pathogenic characteristics. 












DRPLA CAG 6-35 49-88 
HD (Huntington's disease) HTT CAG 6-35 36-250 
SBMA (Spinal and bulbar 
muscular atrophy) AR CAG 9-36 38-62 
SCA1 (Spinocerebellar 
ataxia Type 1) ATXN1 CAG 6-35 49-88 
SCA2 (Spinocerebellar 
ataxia Type 2) ATXN2 CAG 14-32 33-77 
SCA3 (Spinocerebellar 
ataxia Type 3 or Machado-Joseph 
disease) 
ATXN3 CAG 12-40 55-86 
SCA6 (Spinocerebellar 
ataxia Type 6) CACNA1A CAG 4-18 21-30 
SCA7 (Spinocerebellar 
ataxia Type 7) ATXN7 CAG 7-17 38-120 
SCA17 (Spinocerebellar 
ataxia Type 17) TBP CAG 25-42 47-63 
FRAXA (Fragile X syndrome) α FMR1 CGG 6 - 53 > 230 
FXTAS (Fragile X-associated 
tremor/ataxia syndrome) α FMR1 CGG 6 - 53 55-200 
FRAXE (Fragile XE mental 
retardation) α 
AFF2 or 
FMR2 CCG 6 - 35 > 200 
FRDA (Friedreich's ataxia) FXN or X25 GAA 7 - 34 > 100 
DM (Myotonic dystrophy) DMPK CTG 5 - 37 > 50 
SCA8 (Spinocerebellar 
ataxia Type 8) 
OSCA 
or SCA8 CTG 16 - 37 110 - 250 
SCA12 (Spinocerebellar 
ataxia Type 12) 
PPP2R2B or 
SCA12 
nnn On 5' 
end 7 - 28 66 - 78 
αThese syndromes are generally characterized in the clinical setting and 







There a many proposed mechanisms addressing TNR instability that are 
mediated by DNA repair, replication, homologous recombination, and 
transcription.  Every process in which the DNA double-helix is denatured has 
shown to be affected by trinucleotide repeat instability, but the greatest instability 
has been seen during replication and recombination (Cleary and Pearson, 2003; 
Lenzmeier and Freudenreich, 2003).  This implies that DNA replication is the 
initiating event in TNR instability.  During DNA replication and metabolic 
processes, the native DNA double-helix is separated to allow the binding of 
polymerases, transcriptional regulators, stabilizing proteins, and other DNA-
binding motif proteins.  Through slippage of single-stranded DNA (ssDNA), 
intermediate secondary structures are created, also known as TNR hairpins or 
bulky adducts (Kang et al., 1995; Salinas-Rios et al., 2011; Sinden, 2001; Wells et 
al., 1998). These hairpins exhibit increased stability through Watson-Crick 
complementarity of cytosine-guanine base pairing. The subsequent processing of 
replication and ligation will insert newly synthesized tandem repeats, or with a 
lower probability, delete tandem repeats.  The insertion or deletion of newly 
synthesized tandem repeats is dependent on which strand is undergoes slippage.  
When slippage occurs on the template strand, newly synthesized DNA will have 
deleted tandem repeats.  Likewise, if slippage occurs on the nascent DNA strand, 
the subsequent replication products will result in an increase in tandem repeat 
sequences (Fig. 6).  It has been shown that there is greater probability for 
expansions to occur in TNR regions.  It has also been shown that multiple, shorter 
hairpin formations are more favored, versus fewer, longer hairpins (Avila-Figueroa 
et al., 2011; Gacy et al., 1995; Rolfsmeier et al., 2001; Yu et al., 1995; Zacharias, 
2001).  Even though specialized DNA repair mechanisms have evolved to address 
these specific bulky hairpins, it has been shown that DNA repair acts as both 
positive and negative effectors of TNR instability (Cleaver et al., 2009; Kovtun et 
al., 2007; Lin and Wilson, 2012; Liu and Wilson, 2012; Panigrahi et al., 2010; Pinto 
et al., 2013).  Interestingly, the propensity favoring smaller, more frequent hairpins 
increases the probability of multiple hairpins interacting with each other, known as 
duplex formation, which ultimately decreases the efficiency of DNA repair 
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processes (Goula et al., 2012; Lai et al., 2013; Liu et al., 2013; Qiu et al., 2015; Xu 
et al., 2014).  The increase in bulky, localized hairpins is more difficult to resolve 
than fewer hairpins distributed throughout the strand.  Devoid of DNA replication, 
ironically the largest TNR expansions are detected in mitotically inactive cells 
(Kennedy et al., 2003; Kennedy and Shelbourne, 2000; Shelbourne et al., 2007).  
Contrary to logic, the degree of instability and proliferation rate of tissues does not 
seem to be linked, where slowly proliferating liver tissue show moderate instability 
and mitotically inactive striatal tissues show high instability (Fortune et al., 2000; 
Gomes-Pereira et al., 2001; Kennedy and Shelbourne, 2000; Larson et al., 2015; 
Lia et al., 1998; Mangiarini et al., 1997; Wheeler et al., 1999).  With no data 
showing a direct correlation to tandem repeat instability and proliferation rates, it 
is concluded that instability occurs by a mechanism(s) independent of replication 
mediation.  As well, the instability shown in arrested cells implicate the involvement 
of DNA damage repair mechanisms.   
DNA replication and metabolic processes alone did not address tissue-
specific (CAG) mosaicism seen in mitotically inactive neuronal cells.  During mitotic 
arrest, the absence of a sister chromatid/chromosome eliminates the likelihood 
that TNR instability is occurring during homologous recombination.  This rules out 
the chances that striatal neurons are undergoing TNR instability during replication 
or recombination.  The most accepted mechanism of TNR instability in mitotically 
inactive cells is involving transcription, especially in G1/G0-arrested striatal 
medium spiny neurons.  Until recently, proof of concept was shown only in bacteria 
cells, and the data did not provide insights into the mechanism.  These data was 
suggestive that there was interplay between replication and transcription, causing 
the instability (Bowater et al., 1997; Mochmann and Wells, 2004; Parniewski et al., 
1999; Schumacher et al., 2001).  Again, this mechanism seemed unlikely, as 
replication is not a factor in nondividing neurons.  Furthermore, there has been 
instability shown in nonproliferating female germ line and sperm precursor cells 
(Kaytor et al., 1997; Kovtun and McMurray, 2001; McMurray and Kortun, 2003). 
Eventually a mechanism was proposed addressing TNR instability in 
nondividing cells that was replication independent (Mochmann and Wells, 2004).  
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This mechanism proposed that during the strand separation for transcription, 
hairpins would form on both opposing strands, and is referred to as transcription-
coupled trinucleotide repeat instability.  The success by which DNA repair resolved 
the hairpins was the factor that determined whether an expansion or deletion 
occurred (Fig. 7).  If DNA repair pathways recognized and addressed the hairpins, 
the result would be deletions of the sequence composing the bulky adduct.  But, if 
cleavage occurred on the strand opposite of the hairpin, the hairpin would 
eventually resolve itself out of secondary structures.  At this point, DNA repair 
would synthesize missing bases and the product would be an expansion.  While 
this proposed mechanism addresses TNR instability in non-proliferating cells, it is 
highly probable that more than one mechanism is causing TNR instability in 
proliferating cells.   
Trinucleotide repeat instability forms the basis for genetic anticipation, and 
thus the pathogenicity for HD.  Even though the subject is extremely researched, 
we have yet to create any comprehensive mechanism.  Identifying whether one 
mechanism is responsible for the mosaicism of repeat instability in tissues of 
different types, or if different mechanisms are involved for different tissues seems 
to be the starting point.  Most data is pointing to the probability that tissue-
mosaicism is mechanistic-specific as well, which further convolutes the problem 
by identifying all the mechanisms.  Unfortunately, the more data gained only 
presents more questions to ask.  As for HD and our current knowledge of cell 
biology, and knowing disease-affected cells are mitotically inactive, DNA repair 
likely plays a role and is mediated by transcription.  Using proliferating cells in 
studies to determine TNR instability allows for the analysis of collective responses 
by the mechanisms in the cell.  The advantage of using mitotically active cells 
provides a platform to determine, not only the mechanisms involved, but also 
allows for determination of the degree of involvement each mechanism has on 







Fig. 6.  Mechanism for hairpin formation and trinucleotide repeat instability.  
Upon polymerase slippage, single-stranded DNA has anneal to itself.  This 
structure is stabilized through Watson-Crick base pairing of cytosine-guanine 
bonding.  Hairpins in nascent DNA result in expansions (A), where hairpin 
formation in template strands result in contractions (B).  Figure from (Lin et al., 






Fig. 7.  Pathway for transcription-induced triplet repeat instability.  Upon 
transcription termination, separated DNA strands have the propensity to form 
hairpin structures, due to their intrastrand complementarity.  Correct resolution 
of the bulky adducts by DNA repair is determined on how they are addressed.  
Cleavage flanking hairpins themselves results in removal of the complementing 
base pairs composing the hairpins (bottom-left).  Incisions in the opposing DNA 
backbone, opposite to the hairpin, would allow the eventual denaturing of the 
hairpin, leading to genome expansions (bottom-right).  Figure adapted from (Lin 
and Wilson, 2007). 
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DNA repair as effectors of trinucleotide repeat instability 
 DNA damage repair is necessary to preserve genomic integrity from 
damage/mutations caused by both endogenous and exogenous factors. 
Unfortunately, data is emerging that DNA damage repair can inadvertently have 
negative consequences on genome integrity when addressing alterations, 
specifically when addressing repeat expansions (Zhao and Usdin, 2015a).  In most 
instances, DNA repair pathways ensure proper maintenance, addressing DNA 
strand damage induced by endogenous and exogenous mutagens and effectors.  
However, as shown in trinucleotide repeat diseases, new research is uncovering 
ways that DNA repair increases the risk of mutations.  The magnitude and severity 
of the negative effects of dysfunctional DNA repair are dependent upon a number 
of factors, including location of the tandem repeats, size of the repeats, and 
number of repeats within the allele, as well as the specific repeat sequence and 
orientation (Fry and Usdin, 2006).  Also, physical DNA secondary structure and 
conformation during DNA modifications process plays an effector of efficient DNA 
repair.  The physical existence and unique properties of tandem repeats in the 
genome creates a multitude of factors that have challenging characteristics that 
complicate efficient DNA damage repair.    
DNA replication-independent mechanisms suggest that TNR instability in 
proliferation-inactive cells, such as neurons and some germ line cells, is mediated 
by DNA repair.  This proposal warrants consideration based on the fact that TNR 
instability has been shown to occur, unnecessary of cells entering the S-phase of 
the cell cycle.  There are predominantly two general proposed mechanisms of 
replication independent TNR instability.  Both mechanisms involve DNA repair 
responses to bulky adducts and both result in tandem repeat length alterations.  
The first mechanism infers that DNA repair is initiated, resulting in strand nicks at 
damaged bases or at oxidative damage.  The cleaved single strand now has the 
propensity to create complementarily-base hairpins which lead to the insertion of 
tandem repeats.  The second general proposal involves the consequence of 
heteroduplex formation during transcriptional unwinding of the double helix. The 
formation of aberrant DNA structures then initiate a DNA repair response.  In both 
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of these general mechanisms proposed, TRN instability has been shown to occur.  
While these mechanisms provide adequate explanations of TNR instability in 
mitotically inactive cells, they ultimately rely on DNA damage repair mechanisms.  
As well, these mechanisms do not address somatic tandem repeat expansion 
mosaicism witnessed in HD.   
 The most basic process involved in DNA damage repair is mismatch repair 
(MMR).  This repair process is essential to identifying genome regions that are 
highly repetitive and have a propensity to cause DNA polymerase to slip back, thus 
synthesizing extra bases on the nascent strand.  Upon re-annealing of the two 
strands, bulges are created (Jalal et al., 2011).  The MMR response involves the 
formation of Msh2/Msh6 and Msh2/Msh3 complexes that form cyclical structures 
that encompass the DNA strands and detects bulges.  Upon detection of an bulky 
adduct, MutL is recruited to ensure removal of the adduct on the damage strand, 
and that DNA is resynthesized (Weinberg, 2014).  Ironically, more data is coming 
to light that MMR drives triplet repeat expansions (Castel et al., 2010; Halabi et al., 
2012; Kovalenko et al., 2012; Panigrahi et al., 2012; Pinto et al., 2013).  Through 
the use of mouse models, knock-outs of proteins essential to MMR show TNR 
stability is induced, reducing the rate of expansions (Pinto et al., 2013).  Also, there 
has been evidence that increased oxidative damage inhibits the efficacy of MMR 
to properly maintain the genome from MMR-related damage (Chang et al., 2002).  
The combination of these data is difficult to interpret in the context of HD.  These 
data implies that the increased oxidative stress present in HD should inactivate 
MMR, thus stabilizing TNR regions in the genome.  On the other hand, inactivated 
MMR in HD would exacerbate the formation of bulky adducts causes by slipped 
polymerases.  It is evident that further investigation on the role of MMR, possibly 
in conjunction with other repair mechanisms, is needed to discover the 
comprehensive mechanism responsible for TNR instability.     
 Excision repair pathways are the predominant pathways that maintain 
genome integrity.  These pathways address a myriad of DNA lesions, such as 
complex intra-strand formations, to base methylations.  Four basic steps are 
involved in excision repair, with each step absolutely necessary for successful 
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DNA damage repair.  The basic steps are damage recognition, excision of 
damaged bases, synthesis of excised region, and ligation of newly synthesized 
strands.  The response elicited to address this damage is determined by the 
complexity and extent of the damage recognized.  In recent years, it has been 
made evident that there are two distinct pathways in which excision pathways 
address DNA damage, known as base excision repair (BER) and nucleotide 
excision repair (NER).  In the context of tandem repeat expansions and HD, 
components of both excision pathways have been implicated in being effectors of 
TRN instability.   
 The most basic excision repair pathway is base excision repair.  BER 
initiates a series of steps involving proteins to repair a recognized non-bulky lesion 
on a newly synthesized strand.  This damage is predominantly from oxidation, 
deamination, and alkylation to the DNA strand.  Unique to this pathway are a class 
of at least 11 proteins known as glycosylases, which are proteins that recognize 
specific types of damage.  Two sub-pathways of BER exist, in which either 1 
nucleotide is replaced, or 2-13 nucleotides are replaced; dependent upon which 
pathway addresses damage determines which set of proteins are activated to 
conduct necessary repair.  Interestingly, it is shown that knock-out mouse models 
of glycosylases OGG1 and NEIL1 reduces tandem repeat expansions in somatic 
cells (Kovtun et al., 2007; Mollersen et al., 2012).  The primary function of these 
proteins is to identify and excise oxidized bases.  Importantly, the loss of NEIL1 
expression has shown intergenerational reductions in the average size of 
expansions (Mollersen et al., 2012).  Furthermore, apurinic/apyrimidinic 
endonuclease 1 (APEX1) is gaining more attention in research as its role in TNR 
instability is becoming more apparent.  Recent studies show that APEX1 prevented 
expansions with its exonuclease activity in hairpin loop-outs and stem-loops 
(Beaver et al., 2015).  Another study showed that oxidative damage to the bases 
in a hairpin ultimately affected the efficiency of APEX1 to properly address the 
hairpin (Li et al., 2014).  These data further confound the comprehensive model of 
TNR instability, as revealing multiple components of different mechanisms being 
effectors of tandem repeat expansions in the genome.   
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 The last excision-based DNA repair process is nucleotide excision repair 
(NER).  NER is a process that targets DNA damage where bulky lesions have been 
created within the double stranded DNA.  Unlike the previously mentioned repair 
mechanisms, DNA damage caused by ultra-violet radiation is recognized by NER 
(Friedberg, 2011).  The repair of DNA damage by NER involves up to 30 base 
pairs, and is divided into two pathways: transcription-coupled repair (TCR-NER) 
and global genome repair (GGR-NER) (Hanawalt et al., 2000). Though only the 
initial steps of damage recognition differentiate the two sub-pathways, both 
pathways converge for the remaining steps of incision, repair and ligation (Scharer, 
2011).  Both pathways ultimately implement the appropriate base pairs.  
 Global genome repair employs sensing proteins through continuous 
surveying of the DNA strands during transcribed and non-transcribed DNA.  Tight 
stringency is placed on the replication process to ensure the appropriate 
implementation of proper nucleotides.  DNA-damage binding (DDB) proteins and 
the xeroderma pigmentosum, complementation group C - S. cerevisiae Rad23 
homolog  (XPC-hHR23B) complex facilitate proper synthesis by verifying the 
absence of helix distortions created by UV damage.  Upon detection of helix 
abnormalities, the bound complex will initiate the remaining steps of mechanistic 
repair.   
Transcription-coupled repair differs from global genome repair in that it has 
a severely lower efficiency of repairing DNA damage in non-transcribed DNA, 
hence the name ‘transcription-coupled repair’.  The cell does not rely on the 
detection of helix distortions by XPC or DDB proteins.  This pathway is initiated 
when the cell has detected prolonged blockage of RNA polymerase II (RNA pol II).  
In both sub-pathways of NER, once the ultra-violet light induced DNA damage has 
been detected, transcription factor II H (TFIIH), composed of XPD and XPB, 
creates an incision while XPG stabilizes the strands and maintains endonuclease 
properties.  This complex contains other proteins that facilitate helicase activity and 
single-strand DNA protection.   
While extensive research on neurodegenerative-based mouse-models 
shows that NER, and its components affect tandem repeats, currently no data 
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shows that aberrant NER machinery is directly responsible for TNR instability in 
HD pathogenesis.  Loss of XPA induces contractions in specific neuronal tissues 
in SCA1 mouse models (Hubert et al., 2011).  Also, Cockayne Syndrome B (CSB), 
a factor necessary for transcription elongation, induces TNR expansions in FXD 
mice in both germ line and somatic cells (Zhao and Usdin, 2014; Zhao and Usdin, 
2015b).  Interestingly, CSB up-regulates OGG1, NEIL1, and APEX1 expression, 
concluding that it might play an alternate role in BER responses (Muftuoglu et al., 
2009; Tuo et al., 2002; Wong et al., 2007).   
Double-strand breaks (DSB), and its’ subsequent repair introduce severely 
complicated mechanisms, further confounded with a multitude of sequential 
protein recruitments.  The very nature of double-strand breaks in the genome, 
homologous or non-homologous, represents damage from normal cellular 
processes, such as oxidative stress, or it can be in response to severe DNA 
damage from irradiation, chemical agents, or ultra-violet light.  Ultimately, failure 
to repair DSB’s will ultimately lead to cell death.  To increase the complexity of 
repairing DSB’s, there can be a combination of types of chromosomal breaks.  
Fortunately, there are several different mechanisms to address all combinations of 
DSB’s.  The simplest instance would be the utilization of homologous 
recombination, in which same regions of a sister chromosome are used as a 
template to synthesize regions in a damaged strand.  The damaged DNA strand 
undergoes digestion of the damage, and also of flanking bases to expose 
complimentary sequences used for annealing to the sister 
chromatid/chromosome.  Upon completion of single-strand overhangs, the strand 
migrates to its compliment in the sister chromatid/chromosome.  After successful 
sequence pairing, DNA polymerase elongates the damaged strand, pushing the 
non-bound strand out from the chromosome.  The strand from the sister 
chromosome that has been relocated out then becomes a template for DNA 
synthesis for the remaining strand that was initially damaged.  Upon successful 
synthesis of damaged strands, ligation occurs, integrating both newly synthesized 
regions into their respective location in the damaged strand.  This process has 
often been described as “error-free”, as the template for synthesis is from an 
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undamaged, sister chromatid/chromosome, assumed to have an intact and 
function gene sequence region.   
As of now, homologous recombination of DSB repair is the only repair 
mechanism of this type to be implicated in tandem repeat instability.  S. cerevisiae 
Rad52 is a protein that binds the ends of the damaged DSB’s and facilitates its’ 
migration and annealing to the complement strand on the sister 
chromatid/chromosome.  In DM1 mouse models, loss of Rad52 results in germ line 
tandem repeat contractions (Savouret et al., 2003).  There is no evidence as of yet 
that homologous recombination events elicit changes in TNR instability in HD.  
However, data shows that expansions occur in HD haploid sperm in the absence 
of sister chromatids/chromosomes (Kovtun and McMurray, 2001).  The absence 
of an undamaged DSB or sister template eliminates DSB repair as a mediator of 
TNR instability.  Interestingly, Rad52 does interact with OGG1 via BER of DNA 
damage by oxidation, implying that it may have an alternative role in TNR instability 
(de Souza-Pinto et al., 2009). 
To further complicate the pathogenesis of TNR instability in HD, DNA 
synthesizing machinery has been implicated as having effects on tandem repeat 
regions.  DNA polymerases conduct the physical synthesis of new strands or new 
sequences inserted into regions where damaged bases were removed.  Studies 
have implicated DNA polymerases β and δ/ε as effecting TNR regions due to 
polymerase slippage, with ultimately causes “re-synthesis” of previously 
synthesized template regions (Liu et al., 2009; Liu and Wilson, 2012; Sadeghian 
and Ochsenfeld, 2015).   
 It is apparent that TNR instability is, at least partially, a product of aberrant 
DNA repair processes.  Our current knowledge only presents more questions.  All 
four of the general DNA damage repair pathways have been shown to be effectors 
of TNR instability.  Three of the four mechanisms have been validated to be 
involved in HD or HD models.  The fourth mechanism, homologous recombination 
of DSB’s, has only been shown to affect tandem repeat sequences in another TNR 
disorder.  Currently research has not implicated homologous recombination to 
affect HTT gene expansions.  Needless to say, the somatic TNR mosaicism only 
30 
 
further complicates research.  We not only have to identify the direct mechanism 
by which HD TNR instability occurs, but there is evidence of cross-interactions 
between proteins associated with multiple repair pathways.  And still, it is not clear 
if differential somatic TNR instability in each cell/tissue type is the product of the 
same DNA damage response.   
 
Epigenetics and Huntington’s disease 
 The dysfunction that mHtt causes to cellular pathways is extensive.  Direct 
involvement of mHtt has been adequately researched, with the beginnings of many 
investigations involving proteins that directly bind and interact with mHtt.  
Unfortunately there is still a lot of that we don’t know.  There are reports of 
differential homeostatic pathways emerging concerning HD, with results only 
showing that mHtt in involved somehow, but not by direct interaction of known 
factors.  These changes witnessed implies that epigenetic patterning is altered in 
HD.  Although there is much we don’t understand about epigenetic mediation of 
HD, it is firmly understood that the differential epigenetic alterations are facilitated 
by mHtt involvement.   
The most studied epigenetic factor is histone acetylation.  Briefly, residues 
on histone tails can have acetyl groups bound, dispersing the electrostatic charge 
resulting in relaxation of the DNA strand.  The relaxing of the DNA strand promotes 
gene expression.  The opposite, deacetylated residues promote gene down 
regulation, in that the electrostatic charge is localized, promoting DNA strand 
tightening around the histone complex (Kurdistani et al., 2004). Some studies have 
reported differential histone acetylation patterns in HD, while other data contrast 
those findings (Benn et al., 2009; Bobrowska et al., 2011; Buckley et al., 2010).  It 
is thoroughly shown that the presence of mHtt affects gene expression by 
prevention of DNA relaxing around the histone complex (Glajch and Sadri-Vakili, 
2015; Lee et al., 2013; Wang et al., 2014).  The binding and sequestration of CBP 
by mHtt is one of the first dysfunctional epigenetic changes noticed in HD (Steffan 
et al., 2000).  CBP, referenced earlier for its transcription factor properties, also 
functions as a histone acetyltransferase (HAT).  In the presence of CBP, histone 
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complex tails are acetylated, relaxing DNA from around the complex.  This relaxed 
state allows transcriptional regulatory factors the physical space needed to bind to 
regulatory elements (Jiang et al., 2006; Nucifora et al., 2001; Steffan et al., 2000; 
Taylor et al., 2003).  This interaction between mHtt and CBP has been shown in 
many HD models, recently including neuronal cells from HD patients (Hoshino et 
al., 2003; Yeh et al., 2013).  Further, there are multiple data sets reporting 
conflicting information concerning mHtt altering the expression and efficacy of 
histone deacetylases (HDACs), involved in removal of acetyl groups on histone 
tails to tightly package DNA.  Some groups show that some enzymes involved in 
HDAC class I were overexpressed, but this did not result in increased transcript 
levels in cortical and striatal tissue .In contrast, HD mouse models showed 
increases in HDAC class I enzymes and decreases in HDAC class II enzymes, but 
cortical expression was not changed (Quinti et al., 2010).  More so, decreasing 
some HDAC class I and II enzymes did not have an effect on HD pathological 
phenotypes (Benn et al., 2009; Bobrowska et al., 2012; Bobrowska et al., 2011; 
Moumne et al., 2012).  These data clearly demonstrate the variation on HAT and 
HDAC functions that mHtt imparts. 
As well as acetylation of histones, another epigenetic regulatory factor that 
has been shown to be differential in HD is methylation patterning.  Cytosine bases 
to the 5’ side of guanine bases (CpG) can undergo a methylation event at the 5th 
atom of the ring.  The accumulation of this modification in localized regions of gene 
promoters can have profound effects on gene expression.  Increased methylation 
of CpG regions inhibit binding of basal regulatory factors, thus decreasing 
expression.  Also, heavily methylated regions decrease gene expression by 
recruitment of co-repressor complexes (Jaenisch and Bird, 2003).  Initially thought 
to be a completely repressive mechanism, data is emerging that methylation can 
also promote gene expression (Suzuki and Bird, 2008).   
Genome wide studies of methylation patterns in HD have revealed 
extensive differences relative to unaffected models.  These data reveals that 
increased methylation patterns are gene specific, with some having increased 
methylation and some sites have decreased methylation.  Further, these data 
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shows that methylation is not regulated by a stable epigenetic patterning, but 
instead can be the result of cellular processes (Ng et al., 2013).  This study further 
identifies regions of transcriptional factor SOX2, a protein necessary for 
pluripotency, as being heavily methylated in HD mouse models.    
Furthermore, data suggests that differential methylation of CpG sites occur 
in HD.  Presumptively, increased methylated CpG (meCpG) sites would have 
negative effects on the genome, in that spontaneous deamination of meCpG sites 
yield thymine bases.  This formation of thymine can result in a point mutation, 
known as transition mutations.  Transition mutations are changes in a purine 
nucleotide or pyrimidine nucleotide to another purine or pyrimidine nucleotide, 
respectively.  This further complicates HD, in that hyper-methylated regions are 
prone to increased mutation probabilities, resulting in point mutations.   
It is clear that mHtt has a multitude of negative effects on normal cell 
function.  While most pathways that are known to be aberrant have some data 
showing mechanistic interference by mHtt, the differential epigenetic patterning 
mechanisms are still coming to light.  In all the possible effectors of HD 
pathogenesis, it is evident that TNR instability in somatic expansions and 
transmission is most likely a combination of more than one currently defined 
mechanism, if not involving unknown mechanisms.  Clearly, a comprehensive 
model to define pathogenesis and HD TNR instability would employ the 
simultaneous analysis of multiple pathways while introducing modifying gene 
expression assays.   
 
Induced pluripotent stem cells and Huntington’s disease 
 The comprehensive model by which TNR expansions persist in 
neurodegenerative diseases is incomplete.  More so, the mechanism by which 
TNR expansions resulting in genetic anticipation during gene transmission has 
continued to confound as well. Research into these cell-specific models has 
previously been largely held back due to the inability to have access to cell types.  
Prior to the discovery of iPSC, the only method of investigating disease-specific 
cells, striatal neurons, required grossly invasive and were often only attainable by 
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a relatively small portion of researchers.  The ability to reprogram readily 
accessible cell types into induced pluripotent stem cells, and then further target 
their differentiation into disease-specific cell models in vitro provides researchers 
a platform to investigate cellular mechanisms at a molecular level not previously 
possible.  Since the discovery of iPSC reprogramming, iPSC-derived cell models 
have permitted experiments that would otherwise have been impossible, such as 
targeted therapeutics, disease-specific cell characterization, and cell replacement 
(Benraiss and Goldman, 2011; Castiglioni et al., 2012; Chae et al., 2012; 
Consortium, 2012).  Having the ability to create and investigate disease-specific 
cells types allows us to refocus attention into determining the inherent 
pathogenesis of TNR instability.  Determining the relationship between DNA 
damage repair, epigenetic involvement, and tissue-specific TNR instability through 
differentiation is the key to understanding the mechanism by which pathogenic 
genetic anticipation occurs.   
Recent studies have shown that pluripotent cells have enhanced DNA 
repair response and efficacy of nonhomologous end joining and nucleotide 
excision repair, similar to embryonic stem cells (ESCs) (Fan et al., 2011; Luo et 
al., 2012).  Interestingly, iPSCs have also been reported to show increased 
microsatellite instability, devoid of any known DNA repair gene mutations (Luo et 
al., 2012).  While some studies have shown increases of base excision repair 
glycosylases (OGG1 and NEIL1) in neural stem and progenitor cells, other data 
reports down-regulation of BER components XRCC1, LIG1 and LIG3 during 
terminal differentiation (Hildrestrand et al., 2007; Hildrestrand et al., 2009; Narciso 
et al., 2007; Rolseth et al., 2008).  As mentioned previously, over-expression and 
under-expression of DNA repair genes have both positive and negative effects on 
TNR instability.  It is likely that these differential gene expression changes could 
be involved in the TNR instability in HD.   
The field of iPSC is a relatively new field, and provides a tool for any 
researcher group to investigate their niche in their respective disease-specific cell 
type.  In relation to HD, recent data reports 26 differentially expressed genes in 
HD-iPSC models, relative to wild-type iPSCs (Chae et al., 2012).  Interestingly, this 
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same study identified an increase is genes related to oxidative stress, a known 
effector of HD pathogenesis.  Also, they saw decreases in cytoskeletal proteins 
involved in neuronal differentiation, underlying the possibility that neurogenesis is 
aberrant in HD from initial pluripotent cell state. As well, HD-iPSCs show increased 
lysosomal activity, inferring reversion to pluripotency might alleviate mHtt-induced 
aggregates (Camnasio et al., 2012).  Another study showed that it is possible to 
correct the expanded (CAG) TNR region with a normal (CAG) region in HD-iPSC 
using homologous recombination, and further showed that terminal-differentiation 
of the corrected HD-iPSCs into striatal neurons retained the corrected phenotype 
(An et al., 2012).  This study alone emphasizes the importance of iPSC and 
disease-specific-cell models.   
 
Rationale of study and hypothesis 
Huntington’s disease is a neurodegenerative disease that exacerbates itself 
through trinucleotide instability leading to genetic anticipation.  Through cellular 
dysfunction, multiple processes are interrupted, ultimately leading to striatal 
neuron loss.  Of the cellular processes effected in HD, gene expression through 
mHtt interference has been shown to reduce expression of a myriad of genes 
through the inadvertent binding and sequestration of transcription factors and 
epigenetic modifiers.  The disease pathogenesis is poorly understood, as there are 
currently multiple proposed mechanisms postulated to be responsible for somatic 
cell tandem repeat instability mosaicism witnessed in HD.  Currently it is known 
that effectors of TNR instability include replication, DNA damage repair, 
transcription, and endogenous and exogenous stressors.  As well, recent finding 
are implicating epigenetic modifications as having negative effects on TNR 
stability.  DNA damage repair is the central node in all the processes in which TNR 
expansions are allowed to persist.  Thus, it is likely that a combination of these 
processes work in conjunction with each other to allow the pathogenic TNR region 
of the HTT gene to remain uncorrected.     
Our long-term goal is to understand the mechanism by which mHtt affects 
DNA repair gene expression, and the consequence for differential gene 
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expression.  The objective of this research is to explore the relationship between 
HD and the DNA repair gene expression.  Therefore, it is our hypothesis that TNR 
instability is exacerbated by DNA damage repair gene dysregulation in HD.  
Further, we hypothesize that gene expression of selected DNA repair genes is a 
consequence of mHtt interference on epigenetic patterning.  The hypothesis is 
supported by studies demonstrating the extensive transcriptional dysregulation 
caused by the presence of mHtt in the cell, and the known effects differential DNA 
repair regulation can have on TNR instability.  The rational is that elucidating novel 
DNA repair gene regulation, and effectors of the differential gene expression, will 
enhance our knowledge of comprehensive mechanism for TNR instability and 
somatic mosaicism seen in HD.  Here, we used HD-affected fibroblast cells and 
iPSCs to identify novel down-regulated DNA repair genes that are essential to 
genome integrity.  We further determined the extent of the witnessed dysregulation 
and found it to be present in multiple HD samples.  Using pharmacological dose 
treatments to alter epigenetic regulators, we successfully recovered the aberrant 
gene expression.  We also determined that intermittent treatments of 
hypomethylation agent 5-azacytidine induced TNR stability over prolonged 
treatments.  These data reveals that pharmacological intervention to prevent 
somatic instability might be possible.  Reprogramming HD-fibroblasts into a 
pluripotent cell-state revealed that DNA repair gene deficiencies were corrected to 
wild-type levels, elucidating the possibility that global epigenetic changes in 
conjunction with pluripotency affect DNA repair gene expression in HD.  Further, 
determined that HD-iPSC lines shown contraction-biased instability in early 
passages, and then shown enhanced stability in late passages.  This identifies a 
cell-state in HD where mechanisms that address TNR regions are functioning with 
increased efficacy.  Then we determined that further differentiation of HD-iPSC 
lines retain TNR stability.  These two experiments provide essential data to 
identifying the endogenous pathway(s) responsible for TNR instability.  The data 
we present here suggests that TNR instability in HD might, at least in part, be the 
result of mHtt interference with epigenetic regulatory mechanisms associated with 
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DIFFERENTIALLY EXPRESSED DNA REPAIR GENES IN HUNTINGTON’S 
DISEASE FIBROBLASTS  
 
Introduction 
  Huntington’s disease (HD) is an autosomal dominant neurodegenerative 
disease that causes dysarthria, chorea and dementia, as well as emotional and 
psychiatric disturbances (Peyser and Folstein, 1990; Pla et al., 2014).  HD is 
characterized by an uninterrupted trinucleotide repeat (TNR) expansion of a 
normal cytosine-adenine-guanine (CAG)9-34 sequence in the N-terminal coding 
region of the Huntingtin gene (HTT) on chromosome 4p16 (MacDonald et al., 
1993).  Normal 350 kDa  huntingtin protein (Htt) is ubiquitously expressed in all 
tissues and cell types, and is involved in numerous processes including vesicular 
transport, transcriptional regulation, anti-apoptosis, embryonic development, 
hematopoiesis, mitosis and other essential survival pathways (Dragatsis et al., 
2000; Duyao et al., 1995; Gauthier et al., 2004; Marcora et al., 2003; Metzler et al., 
2000; Nasir et al., 1995; Rigamonti et al., 2000).  Translation of the (CAG)n 
sequence produces polyglutamine (polyQ) residues. However, posttranslational 
modification of an expanded mutant huntingtin protein (mHtt) renders short 
fragments of polar poly-Q chains that aggregate and bind to each other and create 
inclusion bodies leading to neuronal degeneration (DiFiglia et al., 1997; Kim et al., 
2006; Schaffar et al., 2004).   
While neuronal death has been strongly associated with HD, several HD 
mouse models have near normal numbers of neurons yet exhibit a disease 
phenotype.  Scientists have linked this neuronal death independent phenotype to 
transcriptional dysregulation (Cha, 2007).  Further studies found that mHtt-induced 
gene expression is altered in HD brain but not limited to neuronal tissue (Cha, 
2007).  mRNA expression abnormalities are thought to arise in part because Poly-
Q aggregate traps (PQATs) hijack and aggregate important transcriptional 
regulators including nuclear protein p53, cyclic AMP-response element (CRE)-
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binding protein (CREB), specific protein-1 (Sp1), CREB-binding protein (CREB-
BP/CBP),  TATA-box-binding protein (TBP), and TATA binding protein (TBP)-
associated factor (TAFII130) (Cha, 2007; Gil and Rego, 2008; Jiang et al., 2006; 
McCampbell and Fischbeck, 2001). 
Though not completely understood, it is widely accepted that during somatic 
DNA replication and modification processes, the (CAG)-TNR expansion involves 
the production of looped intermediates that can form alternate DNA conformations, 
such as slipped-strand structures and hairpins (Sinden, 2001).  These single-
stranded DNA (ssDNA) looped intermediates contain cis-stabilized “Watson-Crick” 
base-pairing of cytosine-guanine through intra-strand complementary base pairs, 
as well as adenine-adenine mismatched base pairs (Gacy et al., 1995; Kovtun and 
McMurray, 2008; Mirkin, 2007).  Trans-factors directly enhance TNR hairpin-
structure instability (expansion and contraction), as previously shown with MSH2, 
MLH1, MLH3, PMS2, and MSH3 (Gomes-Pereira et al., 2004; Halabi et al., 2012; 
Kovalenko et al., 2012; Lin and Wilson, 2009; Pinto et al., 2013).  However, 
expansion increases during replication do not exclusively address the increased 
occurrence of TNR expansions observed in quiescent cells affected by 
neurodegenerative diseases (Gomes-Pereira et al., 2001; Kennedy and 
Shelbourne, 2000).   
Integration of DNA hairpins is facilitated through multiple cellular 
mechanisms, both dependent and independent of genome replication.  Instability 
has been recorded in the transient separated DNA strands during recombination, 
repair, and transcription independent of genome replication (Jakupciak and Wells, 
2000; Lin et al., 2006; Lin et al., 2009; Lopez Castel et al., 2009; Wells et al., 2005).  
In addition, epigenetic modifications and R-loops have involvement in 
transcription-induced (CAG*CTG)-TNR instability.  Despite the extensive list of 
factors involved in TNR instability, a comprehensive model to explain the molecular 
mechanism of TNR instability in HD has yet to be elucidated.     
 DNA repair dogma states that non-canonical structures assembled during 
transcription or replication are identified and addressed appropriately based upon 
the nature and severity of the lesion.  Specifically, mismatch repair, and possibly 
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other repair processes, should address erroneous strand insertions that create 
bulky adducts.  Some studies have implicated individual DNA repair pathways as 
molecular mechanisms for TNR instability (Lai et al., 2013; Liu and Wilson, 2012).  
Currently there is no evidence that HD directly involves DNA repair gene down-
regulation. DNA repair pathways are affected by HD.  Based on published 
observations, we hypothesized that PQATs contribute to decreased mRNA levels 
of essential DNA repair genes, thus facilitating the characteristic trinucleotide 
expansion and impaired damage responses in HD.  Here we measured DNA repair 
gene expression in a HD-affected fibroblast cell line compared to a cell line 
established from a healthy relative. 
  
Materials and methods  
Cell lines and cell culture 
 Early passage control fibroblast line GM-02187 and HD-affected fibroblast 
line GM-03621 was obtained from Coriell Cell Repositories (Camden, NJ).  HD 
patient’s genomic DNA previously sequenced was characterized as having 18 and 
60 (CAG) repeats within exon 1 of the HTT gene.  Cells were maintained at 37°C 
in a humidified incubator with 5% CO2. Normal human fibroblasts and HD-affected 
fibroblasts were cultured in Modified Eagle’s Medium (MEM) (Life Technologies, 
Carlsbad, CA) with 15% fetal bovine serum (FBS; Life Technologies) or 1:1 
Dulbecco’s Modified Eagle’s Medium and MEM (Life Technologies) with 10% FBS, 
respectively as recommended by Coriell.  Cell media also contained 1x 
penicillin/streptomycin and 1x glutamine (Life Technologies).  Cells were seeded 
in T75 cm2 flasks at 5.0 x 104 cells/ml, and medium was changed between 72 and 
96 hours of seeding.  Cells were passaged every 5-6 days using TrypLETM Express 
(Life Technologies) following manufacturer’s instructions.  Use of human cell lines 
purchased was deemed exempt from IRB review, as it is impossible to identify cell 
donors. 
 
RNA isolation and quantification 
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 Upon 70-80% confluency, total cellular RNA was isolated with Direct-zolTM 
RNA MiniPrep kits (Zymo Research, Irvine, CA) according to the manufacturer’s 
protocol.  RNase-free DNase I digestion (50 units) (Roche Applied Science, 
Indianapolis, IN) was performed as recommended.  DNase I Buffer was added to 
RNA samples at 1x.  One µl (2 U) DNase I was added to each 50 µl reaction and 
incubated at 37 °C for 30 minutes. RNA samples were then extracted with 
phenol/chloroform to inactivate DNase I.  After alcohol precipitation, each RNA 
sample was brought up to one µg/µL in DNase-free RNase-free water.  RNA 
quantification was determined by UV absorbance at 260 nm (A260 nm) on a 
NanoDrop 2000 (Thermo Scientific, Wilmington, DE).  RNA quality was deemed 
acceptable with 260/280 ratios around 2.0 and 260/230 ratios slightly higher than 
1.8. 
 
First strand synthesis and PCR arrays 
 One µg of each RNA sample was reverse transcribed into cDNA using RT2 
First Strand Kit (SABiosciences, Valencia, CA) according to manufacturer’s 
instructions.  Normal and HD-affected cDNA was amplified using a RT2 ProfilerTM 
PCR Array for Human DNA Repair and RT2 SYBR Green PCR Master Mix (PAHS-
042) (SABiosciences) to assess mRNA levels.  The PCR array provides optimized 
primers for 84 genes directly involved in human DNA repair, 5 endogenous 
housekeeping genes, as well as reverse-transcriptase and PCR reaction controls.  
PCR array experiments were conducted on a MyiQ2TM Real Time PCR Detection 
System (Bio-Rad, Hercules, CA).  Cycling conditions were as follows: 1 cycle of 
10 minutes at 95°C, 40 cycles of 15 seconds at 95°C and 1 minute at 60°C.   
 Selected gene expression levels of APEX1, BRCA1, and MSH5 were 
independently verified four times using PrimePCR™ SYBR® Green Assays (Bio-
Rad) for human BRCA1 and MSH5, with ACTB as an endogenous normalizer.  
One µg of each purified cellular RNA sample was reverse transcribed using iScript 
(Bio-Rad) at 42°C for 30 minutes in the presence of hexamer and oligo(dT).  
Negative controls included reactions lacking reverse transcriptase or RNA 
template.  Primer sets for ACTB and APEX1 cDNA were created using Beacon 
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Designer software (PREMIER Biosoft International, Palo Alto, CA) and 
synthesized by Integrated DNA Technologies (Coralville, IA).  Primer set 
efficiencies was determined by a dilution series of cDNA in triplicate.  A 100 bp 
ACTB fragment was amplified with the following primer set: 5’-
AGCCTCGCCTTTGCCGATCC-3’ (Tm 62.3 °C) and 5’-
ACATGCCGGAGCCGTTGTCG-3’ (Tm 62.8 °C).  A 317 bp APEX1 fragment was 
amplified using the following primer set: 5’-GACAAAGAGGCAGCAGGAGAGG-3’ 
(Tm 59.8 °C) and 5’-GGGCACTGGCGGGAAAGC-3’ (Tm 62.7 °C).  All DNA repair 
gene expression was performed by real-time PCR amplification with a MyiQ2TM 
Real Time PCR Detection System.  In detail, each 20 µl qPCR reaction with Prime 
PCR™ assays contained: 1x gene specific PrimePCR assay mix, 1x SsoAdvanced 
Universal SYBR® Green Supermix, and 100 ng of cDNA sample.  Mastermix for 
ACTB and APEX1 in a 20 µl reaction included: 1 x SsoAdvanced Universal SYBR® 
Green Supermix, 0.5 nM of each primer, and 100 ng of cDNA template.  Reaction 
cycling parameters were polymerase activation at 95.0 °C for 120 seconds, 
followed by 40 cycles of 95.0 °C for 15 seconds and 60.0 °C for 30 seconds.  A 
melt curve analysis was conducted afterward where the temperature was lowered 
to 65.0 °C, and then increased in increments of 0.5 °C every 5 seconds to 95.0 °C.   
 
Data analysis 
 HD-affected and control fibroblast RT2 Profiler PCR Array experiments were 
carried out four times.  Cycle-threshold analysis of targeted genes was initially 
conducted by online analysis software provided by SABiosciences specifically 
designed for the RT2 ProfilerTM Human DNA Repair PCR Array.  Fold regulation 
was determined by the ratio of the measured value (2(-ΔCt)) for an HD-affected 
sample to the value (2(-ΔCt)) for the wild-type control.  For PCR array independent 
validation, gene expression levels of APEX1, BRCA1 and MSH5 were verified 
against the initial experiment four times using ACTB to normalize.    Comparative 
analysis was conducted using the ΔΔCT method (Livak and Schmittgen, 2001).  





 All experiments were conducted three to five times with sub-sampling of 
each independent quantitative experiment. Statistical significance was determined 
by a two-tailed, heteroscedastic student T-test. 
 
Results 
Differential expression of DNA repair genes in one HD fibroblast line 
Total mRNA of HD affected fibroblasts and unaffected fibroblasts were 
extracted and analyzed using RT2 ProfilerTM PCR Array for Human DNA Repair.  
The RT2 ProfilerTM PCR Array allowed evaluation of gene expression for 84 genes 
vital to successful recognition and repair of DNA damage (Table 2).  Each 
individual well of the assay contained validated primers related to base-excision 
repair, mismatch repair, nucleotide excision repair, double-strand break repair, 
single-strand DNA stability, and post-repair modification.   
The results show consistent down-regulation of multiple genes involved in 
base-excision repair, mismatch repair, nucleotide excision repair, and other 
accessory genes involved in DNA repair (Fig. 8).  The scatter plot is of the log base 
10 of the hybridization intensity of each gene in the two samples.  The lines above 
and below represent a 3-fold change in gene expression threshold.  The middle 
line represents a fold-change (2-ΔCt) of 1.  Of the 84 genes examined through the 
assay, 11 genes show significantly deficient levels and 1 gene showed an increase 
in expression in HD affected cells.  Expression levels of 53 genes remained 
consistently regulated (< 2- fold) between the wild-type sample GM02187 and HD 
sample GM03621, showing no significant differences, while 18 additional genes 
showed decreased fold changes between 2 and 3.  The 11 points below the bottom 
line indicate down-regulated (ATXN3, CCNO, DMC1, EXO1, LIG3, MSH5, NTHL1, 
RAD18, RPA1, XPC, and XRCC6BP1) genes greater than 3- fold.  Up-regulated 
and down-regulated genes in HD cells and the control cells are summarized in 
Table 3.  The 1 point above the top line indicate up-regulated (XRCC6) gene.  
Statistically significant down-regulation of the XRCC6BP1, DMC1, and RPA1 
genes were found (p < 0.05).  Endogenous housekeeping genes used was B2M, 
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HPRT1, GAPDH, and ACTB.  A fifth housekeeping gene is provided in the array 
































Table 2  
DNA repair related genes analyzed using the RT2 Profiler™ Array. 




(multifunctional DNA repair 
enzyme) 1 




complementation group 3 
(xeroderma pigmentosum 










complementation group 4 
 






complementation group 5 
 




complementation group 6 
 ATXN3 Ataxin 3     
 




complementation group 8 
 BRCA2 Breast cancer 2, early onset   EXO1 Exonuclease 1 
 BRIP1 
BRCA1 interacting protein C-
terminal helicase 1   FEN1 
Flap structure-specific 
endonuclease 1 
 CCNH Cyclin H   LIG1 
Ligase I, DNA, ATP-
dependent 
 CCNO Cyclin O   LIG3 
Ligase III, DNA, ATP-
dependent 
 CDK7 Cyclin-dependent kinase 7   LIG4 
Ligase IV, DNA, ATP-
dependent 
 




DDB2 Damage-specific DNA binding protein 2, 48kDa   MLH1 
MutL homolog 1, colon 












complementing rodent repair 
deficiency, complementation 
group 1 (includes overlapping 
antisense sequence) 
  MMS19 
MMS19 nucleotide excision 





complementing rodent repair 
deficiency, complementation 
group 2 





Gene Description  Gene Description 
 MRE11A 
MRE11 meiotic 
recombination 11 homolog A 
(S. cerevisiae)  
RAD21 RAD21 homolog (S. pombe) 
 MSH2 
MutS homolog 2, colon 
cancer, nonpolyposis type 1 
(E. coli)  
RAD23A RAD23 homolog A (S. cerevisiae) 
 MSH3 MutS homolog 3 (E. coli)  RAD23B 
RAD23 homolog B (S. 
cerevisiae) 
 MSH4 MutS homolog 4 (E. coli)  RAD50 
RAD50 homolog (S. 
cerevisiae) 
 MSH5 MutS homolog 5 (E. coli)  RAD51 
RAD51 homolog (S. 
cerevisiae) 
 MSH6 MutS homolog 6 (E. coli)  RAD51C 
RAD51 homolog C (S. 
cerevisiae) 
 MUTYH MutY homolog (E. coli)  RAD51B 
RAD51 homolog B (S. 
cerevisiae) 
 
NEIL1 Nei endonuclease VIII-like 1 (E. coli)  RAD51D 
RAD51 homolog D (S. 
cerevisiae) 
 
NEIL2 Nei endonuclease VIII-like 2 (E. coli)  RAD52 
RAD52 homolog (S. 
cerevisiae) 
 
NEIL3 Nei endonuclease VIII-like 3 (E. coli)  RAD54L RAD54-like (S. cerevisiae) 
 
OGG1 8-oxoguanine DNA glycosylase  RFC1 
Replication factor C 
(activator 1) 1, 145kDa 
 PARP1 
Poly (ADP-ribose) 
polymerase 1  RPA1 




polymerase 2  RPA3 

















segregation increased 2 (S. 
cerevisiae) 
 TDG Thymine-DNA glycosylase 
 PNKP 
Polynucleotide kinase 3'-
phosphatase  TOP3A 
Topoisomerase (DNA) III 
alpha 
 POLB 
Polymerase (DNA directed), 
beta  TOP3B 




delta 3, accessory subunit  TREX1 
Three prime repair 
exonuclease 1 
 POLL 
Polymerase (DNA directed), 






 XAB2 XPA binding protein 2 
  
RAD18 RAD18 homolog (S. cerevisiae)  XPA 
Xeroderma pigmentosum, 






Gene Description  Gene Description 
 
XPC Xeroderma pigmentosum, complementation group C   
XRCC6BP1 XRCC6 binding protein 1 
 
XRCC1 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 1   
B2Ma Beta-2-microglobulin 
 XRCC2 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 2 
  HPRT1a Hypoxanthine phosphoribosyltransferase 1 
 
XRCC3 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 3   
RPL13Aa Ribosomal protein L13a 
 
XRCC4 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 4   
GAPDHa Glyceraldehyde-3-phosphate dehydrogenase 
 
XRCC5 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 5 (double-
strand-break rejoining)   
ACTBa Actin, beta 
  
XRCC6 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 6   
HGDCb Human Genomic DNA Contamination 
αThe RT2 PCR Profiler Array for Human DNA Repair contains validated and 
optimized primer sets for 84 genes associated with human DNA repair pathways 
including base excision repair, nucleotide excision repair, mismatch repair, and 
single- and double- strand break repair.  The array also contains 5 housekeeping 
genes to normalize expression between tested samples, as well as negative 
controls to detect contamination.  aHouse keeping genes.  bHuman genomic 










































Fig. 8.  Expression of 84 DNA repair genes in HD-affected fibroblasts vs. wild-
type fibroblasts.  Scatter plot of the log base 10 hybridization intensity of each 
DNA repair gene.  The x-axis is wild-type fibroblasts and the y-axis is HD-
affected fibroblasts.  A fold-change (2-ΔCt) of 1 is represented by the middle line.  
The top and bottom lines represent the desired gene expression threshold in 
fold-change (3).  The 11 points below the bottom line represent ATXN3, CCNO, 
DMC1, EXO1, LIG3, MSH5, NTHL1, RAD18, RPA1, XPC, and XRCC6BP1.  The 





Table 3  
RT2 Profiler Array differentially expressed DNA repair genes and pathway 
involvement. 
Gene DNA Repair Pathway Involvement 
Fold 
change 95% CI P-value 
Down-regulated     
 CCNO Base Excision Repair 0.2235 ( 0.00001, 0.91 ) 0.355084 
 LIG3 Base Excision Repair 0.2990 ( 0.00001, 0.70 ) 0.257783 






0.7416 ( 0.07, 1.42 ) 0.60676 













0.3249 ( 0.12, 0.53 ) 0.020691 
 EXO1 Mismatch Repair 0.3138 ( 0.00001, 0.83 ) 0.179559 
 MSH5 Mismatch Repair 0.3238 ( 0.12, 0.53 ) 0.076045 
 ATXN3 Nucleotide Excision 0.2395 ( 0.02, 0.46 ) 0.086207 
 RAD18 Post-replication repair of damaged DNA 0.2585 ( 0.00001, 0.54 ) 0.081376 
 RPA1 Stabilizes ssDNA intermediates 0.2580 ( 0.09, 0.43 ) 0.022726 







3.1670 ( 0.00001, 12.80 ) 0.991114 
Housekeeping genes    
 B2M  1.2554 ( 0.00001, 2.99 ) 0.769982 
 HPRT1  0.9514 ( 0.00001, 2.35 ) 0.647336 
 GAPDH  1.1612 ( 0.08, 2.24 ) 0.978881 
  ACTB   0.7210 ( 0.00001, 2.08 ) 0.458981 
αDown-regulated DNA repair genes in HD cell line GM03621 in the RT2 Profiler™ PCR Array 
for Human DNA Repair.  Fold changes are relative to wild-type cell line GM02187.  
Expression is determined using the 2(-ΔΔCT).  Bolded p-values represent statistical 





Independent confirmation of DNA repair gene down-regulation 
Upon reviewing the mRNA expression data from the RT2 ProfilerTM PCR 
Array, APEX1, BRCA1, and MSH5 consistently showed down-regulation (Fig. 9).  
As per the analysis software provided, the mean 2-ΔCt of the four experiments is 
utilized for fold change.   APEX1, BRCA1, and MSH5 are arbitrarily set at a fold 
expression of 1 in the control sample.  A trend was observed in the down-regulation 
of these genes, though statistical significance was inconclusive, the substantial 
down-regulation warranted further investigation.  Therefore APEX1, BRCA1, and 
MSH5 were selected to be independently verified through additional experiments 
including new extractions analyzed with real-time PCR using PrimePCR™ Assays 
(Bio-Rad). 
PrimePCR™ Assays provided primers that were verified and optimized to 
confirm our initial findings from the RT2 Profiler™ PCR Array.  Four independent 
analyses of APEX1, BRCA1, and MSH5 mRNA levels using PrimePCR™ Assays 
revealed similar decreases in expression levels in each gene.  For each 
experiment, the individual fold expression (2-ΔΔCt) is averaged.  Error bars indicate 
standard error of fold expression across the four experiments.  ACTB was used as 
a housekeeping gene.  Statistical analysis revealed that APEX1 was significantly 
down-regulated.  Although not statistically significant, down-regulation of BRCA1 
and MSH5 was similar with PrimePCR™ Assays as we had seen previously with 
the RT2 Profiler™ PCR Array (Table 4).  This consistent down-regulation verifies 












Fig. 9. Verification of APEX1, BRCA1 and MSH5 down-regulation in HD-affected 
fibroblasts using PrimePCR™ Assays.  The mRNA level is presented in relation 
to control group, wild-type unaffected fibroblast line GM02187, with mRNA levels 
of targeted genes arbitrarily set up as 1.  Error bars represent the standard 






















Independent verification of selected DNA repair gene expression using 
PrimePCR™ Assays. 
         Gene Fold change 95% CI P-value 
Down-regulated    
 APEX1 0.3744 ( 0.07, 0.68 ) 0.026029 
 BRCA1 0.7416 ( 0.07, 1.42 ) 0.60676 
 MSH5 0.5689 ( 0.13, 1.04 ) 0.287329 
Housekeeping gene   
  ACTB 1 ( 1.00, 1.00 ) 0 
αValidation of gene expression of APEX1, BRCA1, and MSH5 of HD cell line 
GM03621 using PrimePCR™ Assays.  Beta-actin was used as an 
endogenous normalizing gene.  Gene expression was determined using the 
2(-ΔΔCT) method relative to wild-type cell line GM02187.  Statistical significance 





In this preliminary study we discovered HD-affected fibroblasts have an 
overwhelming number of down-regulated DNA repair genes in the absence of any 
known DNA repair gene mutations.  Using qPCR-based assays we compared the 
expression of 84 DNA repair genes of HD-affected fibroblasts to unaffected 
fibroblasts.  We initially identified 29 genes down-regulated and 4 genes up-
regulated greater than 2-fold.  To our knowledge, this is the first report of DNA 
repair gene down-regulation in HD.  Using the RT2 ProfilerTM PCR Array for Human 
DNA Repair we demonstrate the down-regulation of multiple genes involved in 
base excision repair, nucleotide excision repair, mismatch repair, double-strand 
break repair (homologous and nonhomologous end-joining), as well as accessory 
genes involved in strand stabilization and polymerase activation. 
We further verified decreased expression of APEX1, BRCA1, and MSH5 
each necessary for successful completion base excision repair, mismatch repair, 
and double-strand break repair.  Using PrimePCR™ Assays we independently 
verified the expression levels of APEX1, BRCA1, and MSH5.  Both qPCR-based 
assays yielded similar decreased levels of these genes.  Based upon the reduction 
in mRNA of these genes, attenuated levels of APEX1, BRCA1, and MSH5 proteins 
are likely to be observed in future studies.  Aberrant DNA repair mRNA 
compromise efficiency of repair machinery to address damaged DNA and non-
canonical secondary structures created during DNA modification.  Through the 
inability to address ssDNA loop-outs, TNR instability maintains and expansions 
persist.   
HD is a dynamic mutation disease, where the number of (CAG) repeats 
increases the probability of expression of the mutant phenotype.  People with fewer 
than 35 (CAG) repeats are not affected by the disease, but individuals with 35 to 
40 repeats are at an increased risk of developing HD.  Expansions greater than 40 
repeats inevitably lead to HD progression (Bates, 2003).  Though the mechanism 
is not fully understood, HD-affected individuals exhibit genetic anticipation caused 
by subsequent generations of HD-affected individuals developing expanded 
versions of the mutated allele (Langbehn et al., 2004; Langbehn et al., 2010; 
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Ranen et al., 1995).  Increased expansion in successive generations correlates 
with more severe symptomatic expression and earlier age of onset in 70% of 
individuals (Lee et al., 2012; Walker, 2007).  Dysfunctional DNA repair pathways 
would likely have implications on the severity of genetic anticipation experienced 
in HD.  
 Translation of the mHtt (CAG)n sequence present in HD patients produces 
repetitive poly-Q fragments that aggregate, thereby trapping and sequestering key 
cellular proteins.  Effects of disease-causing poly-Q fragments in disruption of 
transcriptional regulation by binding of poly-Q residues to other proteins with 
similar amino acid sequences have been extensively reported.  Poly-Q aggregate 
traps (PQATs) hijack important transcriptional activators and disrupt transcriptional 
pathways including cyclic adenosine monophosphate responsive element-binding 
protein (CREB), CREB-binding protein (CREB-BP/CBP), transcription factor Sp1 
(Sp1), transcription factor II D (TFIID), transcription factor II F (TFIIF), and TATA-
box-binding protein (TBP) (Dunah et al., 2002; Kazantsev et al., 1999; Nucifora et 
al., 2001; Shimohata et al., 2000a; Zhai et al., 2005).  Based on the down-
regulation detected of APEX1, BRCA1, and MSH5 mRNA in HD-affected 
fibroblasts, we examined each gene’s respective promoter regions.  Surprisingly 
this examination revealed APEX1 and BRCA1 are regulated by transcription 
factors Sp1, CREB and CREB-BP/CBP, while MSH5 has a Sp1 binding site (Atlas 
et al., 2001; Grosch and Kaina, 1999; Harrison et al., 1995; Xu et al., 1995).  
Sequestration of CBP by PQAT involvement is linked to the increased methylation 
and hypoacetylation of histones in HD (McFarland et al., 2012; Sadri-Vakili et al., 
2007).  PQAT involvement with CBP, and acetyltransferase activity through the 
associated CBP/p300 complex, gives rise to the possibility that direct 
transcriptional regulatory sequestration, histone modification, and chromatin 
remodeling may partially be an underlying factor for the DNA repair gene down-
regulation  observed in our study (Gardian et al., 2005; Ng et al., 2013; Ryu et al., 
2006; Steffan et al., 2001; Steffan et al., 2000).  Though not within the scope of 
this study, it would be logical to address the transcriptional regulatory machinery 
54 
 
for each of the down-regulated genes in HD-affected cells thoroughly characterize 


























DNA METHYLTRANSFERASE INHIBITOR 5-AZACYTIDINE RECOVERS DNA 
REPAIR GENE EXPRESSION AND STABILIZES TRINUCLEOTIDE REPEATS 
IN HUNTINGTON'S DISEASE FIBROBLASTS 
 
Introduction 
Huntington’s disease (HD) is a neurodegenerative disease that affects 
medium spiny neurons in the basal ganglia, resulting in involuntary muscle 
movements and ultimately leading to death. It is caused by an expansion of 
cytosine-adenine-guanine (CAG) trinucleotide repeat (TNR) region in exon 1 of the 
huntingtin (HTT) gene (MacDonald et al., 1993). HD is a dynamic mutation 
disease, where the number of (CAG) repeats increases the probability of 
expression of the mutant phenotype.  People with fewer than 35 (CAG) repeats 
are not affected by the disease, but individuals with 35 to 40 repeats are at an 
increased risk of developing HD.  Expansions greater than 40 repeats inevitably 
lead to HD progression (Bates, 2003).  Though the mechanism is not fully 
understood, HD-affected individuals exhibit genetic anticipation caused by 
subsequent generations of HD-affected individuals developing expanded versions 
of the mutated allele (Langbehn et al., 2004; Langbehn et al., 2010; Ranen et al., 
1995).  It has been shown that increased expansions in successive generation’s 
correlates with more severe symptomatic expression and earlier age of onset in 
70% of individuals (Lee et al., 2012; Walker, 2007).  Interestingly, post-mortem 
analysis of affected cells and other somatic tissues in HD- and other polyglutamine 
(poly-Q) disease- mouse models reveals disease-causing gene (CAG) mosaicism, 
in which (CAG)’s of different tissues have different sized expansions (Fortune et 
al., 2000; Gomes-Pereira et al., 2001; Kennedy and Shelbourne, 2000; Telenius 
et al., 1994).  As well, a myriad of TNR instability effectors have been identified, 
such as environmental stresses, chemical inducers, and DNA repair gene 
expression (Chatterjee et al., 2015; Gomes-Pereira et al., 2004; Gomes-Pereira 
and Monckton, 2004; Kovalenko et al., 2012; Wheeler et al., 2007).  This evidence 
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alone infers that TNR instability is not only present in germ line cells, but also 
throughout development and maturation, and thus dependent upon efficacy of 
DNA repair and its’ ability to appropriately respond to endogenous and exogenous 
DNA damaging agents and modifiers.  The purpose of this study was to investigate 
DNA repair gene expression in HD fibroblasts.   
 There are multiple possible mechanisms proposed explaining TNR 
expansions leading to genetic anticipation, such as polymerase slippage and 
stabile heteroduplex formation.  Unfortunately, the comprehensive mechanism of 
TNR instability eludes researchers.  Of the proposed mechanisms, heteroduplex 
formation and its’ inability for successful resolution are the common factor behind 
TNR instability (Lee and McMurray, 2014).  Through intra-stand complimentary 
base pairing, single-stranded DNA (ssDNA) creates secondary structures, such as 
hairpins or loop-outs (Sinden, 2001).  The ssDNA lesion is stabilized through 
cytosine-guanine hydrogen bonding (Gacy et al., 1995; Kovtun and McMurray, 
2008; Mirkin, 2007).  Though this secondary structure meets the criteria for DNA 
damage as we understand, the lesion is ignored and the result is an incorrect 
number of CAG repeats.  These expansions lead to earlier onset and more severe 
symptoms during disease progression.  Interestingly, expansion in the HTT gene 
has been reported in both mitotically active and quiescent cells.  Tissue specific 
analysis of R6/2 mouse-models show large variability in CAG repeats, with 
mitotically inactive striatal tissue samples revealing greater CAG expansions in the 
HTT gene (Fortune et al., 2000; Vatsavayai et al., 2007).  Prevention of TNR 
expansions is not only the key to understanding the pathogenesis of HD, but also 
essential to the development of pharmaceutical treatments.   
Pathology of HD involves cellular dysfunction on multiple levels.  The 
elongated gene encodes for repetitive glutamine amino acids, in which these 
polyglutamine (poly-Q) chains contain hydrophobic properties.  A number of 
studies have suggested that post-translational cleavage of huntingtin protein 
renders a shorter N-terminal fragment with the poly-Q expansion (Kim et al., 2006; 
Ratovitski et al., 2009).  The mhtt protein and potential fragments created exhibits 
a toxic gain-of-function, in which poly-Q chains bind unintended targets, 
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sequestering them from normal function (Nucifora et al., 2001).  Poly-glutamine 
regions of wild-type and mhtt physically interact many DNA-binding proteins 
(Seredenina et al., 2011).  Consequently, expanded poly-Q regions of mHtt have 
been show to disrupt normal cell functions through interaction with multiple basal 
transcription factors causing gene expression dysregulation, including CREB, 
CREBBP, Sp1, TFII30, NRSF/REST, PFC1α, BCL11b, TBP, and others (Dunah 
et al., 2002; Kazantsev et al., 1999; Li et al., 2002; Seredenina and Luthi-Carter, 
2012; Steffan et al., 2000; Zhai et al., 2005).   
Another proposed mechanism of HD pathology is the involvement of mhtt 
on DNA methylation patterning.  It is established that gene silencing can be a result 
of increased DNA- and histone- methylation.  ERG-associated protein with SET 
domain (ESET), a regulator of H3 trimethylation, shows increased expression in 
HD and can be therapeutically addressed, thus increasing neuronal survival in the 
R6/2 mouse model (Ryu et al., 2006).  Furthermore, extensive changes in DNA 
methylation is associated with the expression of mHtt.  Interestingly, these 
changes in methylation patterns seem to be sequence- specific to DNA binding 
motifs (Ng et al., 2013).  While it seems that researchers haven’t seen direct protein 
to protein interactions between mHtt and methyltransferases, the probability that 
either gain-of-function mHtt, or the loss of wild-type Htt, has an impact on 
epigenetic imprinting.   
        The detection and identification of methylation as regulatory effects on gene 
expression involves a multi-step process.  Prior to quantitative gene expression 
assays, such as qPCR, extracted gDNA samples are exposed to bisulfite 
treatments.  This method exploits the ability of unmethylated cytosine residues to 
undergo conversion to uracil.  This conversion leads to subsequently created 
strands (through amplification processes) having thymine incorporated within the 
strand in place of the unmethylated cytosine.  Methylated cytosine resist the 
transformation to uracil, thus further copies of methylated cytosine nucleotides 
maintain the natural cytosine incorporation.  Using nucleotide identification 
techniques, primarily capillary electrophoresis sequencing, researchers are able 
to accurately detect methylation patterns and levels in genes and regions flanking 
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genes.  The amount of methylation present in regions flanking transcriptional start 
sites are known to effect transcriptional regulation.  It has been previously agreed 
upon that increased methylation patterning in regions encompassing 
transcriptional start sites has negative effects upon gene expression.  Interestingly, 
there is some data suggesting that increased methylation patterns can have 
increased-expression effects as well (Suzuki and Bird, 2008).  After successful 
bisulfite treatments, workflows remain the same using sequencing techniques to 
accurately identify chemically-replaced cytosines with thymines in bisulfite treated 
and non-treated samples.   
Here we hypothesize that HD fibroblasts would have abnormal expression of 
DNA repair genes, sensitizing them to (CAG) TNR expansions.  We determined 
that key DNA repair genes were down-regulated in HD fibroblasts compared to 
wild-type controls.  Cell lines pHD-1 and pHD-2 had expansions of 17/42 and 18/44 
respectively, and treatment with 5-azacytidine resulted in increased DNA repair 
expression and stabilization of (CAG) repeats during culture.  This is the first study 
to identify endogenously deficient DNA repair genes in human fibroblasts and is 
proof of principle that pharmacological intervention could lead to increased (CAG) 
stability in patients at risk for the disease.    
 
Materials and methods 
Cell lines and cell culture   
Three previously confirmed HD (GM03621, GM02079, and GM03868), two 
wild-type (GM02187 and GM02153), and two unknown (GM02191 and GM04022) 
fibroblast cell lines were obtained from Coriell Cell Repositories (Camden, NJ).  
Unknown fibroblast samples were obtained from donors of which one parent was 
confirmed to be affected by HD, but were not diagnosed.  Genetic characteristics 
of exon 1 of the HTT gene of each cell line used in our experiments are determined 
later, and referenced in Table 6.  Cell lines were cultured and maintained at 37°C 
in a humidified incubator with 5% CO2. Fibroblasts were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Life Technologies, Carlsbad, CA) with 10% 
fetal bovine serum (FBS; Life Technologies) as recommended by Coriell.  Cell 
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media also contained 1.0% Antibiotic-Antimycotic (100X) (ABAM; Life 
Technologies).  Cells were seeded in T75 cm2 flasks at 5.0 x 104 cells, and medium 
was changed between 72 and 96 hours of seeding.  Cells were passaged every 5-
6 days using TrypLE™ Express (Life Technologies) following manufacturer’s 
instructions.  Use of human cell lines purchased was deemed exempt from IRB 
review, as it is impossible to identify cell donors.   
 
5-Azacytidine and trichostatin-A treatment   
Wild-type and HD fibroblasts were grown in culture for 24 hours and then 
treated with a serial dilution of 5-azatacytidine (Sigma Aldrich; St. Louis, MO) 
reconstituted in phosphate-buffer saline (PBS) to determine LC50 for 120 hours 
(data not shown).  Serial dilution concentrations were 20, 10, 5, 1, 0.5 µM.  LC50 
was determined to be 10 µM.  At cell passaging, cell media was supplemented 
with 5-azacytidine to achieve 10 µM.  Cell sample media was replaced daily with 
supplemented media for 5 days.  At the end of 5 days, cells were washed and 
gDNA and total RNA was collected.   
Cell lines pHD-1 and pHD-2 were plated in T-75 flasks and treated 
intermittently with 10 µM 5-azacytidine over the course of 35 days to reach four 
population doublings.  Treatment schedule was as follows;  Pass in normal 
medium for 24 hours, treat with 10 µM 5-azacytidine for 5 days, allow cells to 
recover for 3 days in normal medium, repeat with passaging at a 1:4 split ratio.  
During 5-azacytidne treatment days, cells were washed with PBS 2x before 
replacing the medium supplemented with 5-azacytidine.  Genomic DNA samples 
were collected at the beginning of each treatment schedule and at the end of the 
designated time frame. 
For histone-deacetylase inhibition (HDACi) treatment, complete fibroblast 
medium was supplemented with 0.5 µM and 5.0 µM trichostatin-A (TSA) (Sigma 
Aldrich) reconstituted in DMSO to achieve 0.01% v/v.  TSA containing media was 
applied 16 hours after passaging cells, and allowed to remain for 24 hours.  Upon 




RNA isolation, quantification, and first strand synthesis  
 Upon 70-80% confluency (approximately one million cells), total cellular 
RNA was isolated with Tri-zol™ (Thermo Fisher, Waltham, MA) following the 
phenol: chloroform manufacturer’s protocol.  To ensure pure RNA samples, 
RNase-free DNase I digestion (50 units) (Roche Applied Science, Indianapolis, IN) 
was performed as recommended.  RNA quantification was determined by UV 
absorbance at 260 nm (A260 nm) on a NanoDrop 2000 (Thermo Scientific, 
Wilmington, DE).  RNA quality was deemed acceptable with 260/280 ratios around 
2.0 and 260/230 ratios slightly higher than 1.8.  One µg of each RNA sample was 
reverse transcribed into cDNA using Platinum™ Taq DNA Polymerase High 
Fidelity Kit (Thermo Fisher) according to manufacturer’s instructions.  cDNA 
samples were further diluted to a concentration of 5-10 ng/µL in dnase-free, rnase-
free water.   
 
Quantitative real time PCR   
Wild type, HD, and unknown cDNA samples was amplified using TaqMan® 
Gene Expression Assay (Applied Biosystems, Foster City, CA.) to assess mRNA 
levels.  TaqMan® Gene Expression Assays provided optimized primers and 
probes specific for DNA repair genes APEX1 (Hs00959050_g1), BRCA1 
(Hs01556193_m1), RPA1 (Hs00161419_m1), and RPA3 (Hs01047933_g1); and 
the endogenous housekeeping gene ACTB (Hs99999903_m1).  Real-time 
quantitative PCR experiments were conducted with a StepOnePlus™ Real-Time 
PCR System (Applied Biosystems, Foster City, CA).  Probes consist of 5’ terminal 
reporter dye FAM (6-caroxyfluorescein) and 3’ terminal quencher dye NFQ-MGB.  
TaqMan® Fast Advanced Master Mix (Life Technologies) was used in conjunction 
with TaqMan® Gene Expression Assays.  Complete reactions were conducted in 
20 µL volumes and contained 1X TaqMan® Fast Advanced Master Mix, 1X 
TaqMan® Gene Expression Assay, and 50 ng of cDNA template.  All qPCR 
experiments included NTC and NRT controls to assure results were not from 
contaminating nucleic acid in either PCR or cDNA reactions.  Thermal cycling 
conditions were as follows: 1 cycle of 2 minutes at 50°C, 1 cycles of 20 seconds 
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at 95°C, and 40 cycles of 1 second at 95°C and 20 seconds at 60°C.  All 
experiment reactions were independently completed in triplicate.  Negative 
template controls were run on each experiment containing nuclease-free water.  
All cell lines were tested 3 independent times, with at least 2 population doubling 
events occurring between sample experiments.  Each experimental sample was 
sub-sampled 3 times during qPCR reactions.  Error bars represent the standard 
deviation of three independent experiments conducted in triplicate.  ACTB was 
used as our endogenous housekeeping gene for normalization.   
 
Immunofluorescence of DNA repair genes   
Cell samples were seeded onto Lab-Tek microscope chamber slides at a 
density of 1.5*103 cells/ml.  Cells were washed three times with phosphate-
buffered saline (PBS).  Slides were fixed with 10% formalin for 30 min at room 
temperature, followed by PBS washing three times.  Samples were blocked with 
10% goat serum for 60 min at room temperature.  Primary antibodies were 
obtained from ABCAM (Cambridge, MA).  APEX1 antibody (ab105081; 1:700), 
BRCA1 antibody (ab16781; 1:250), RPA1 antibody (ab79398; 1:250), and RPA3 
antibody (ab6432; 1:50) were diluted in 1.0% goat serum and applied overnight in 
a humidified chamber at 4.0°C.  Each sample slides contained designated 
chambers lacking the addition of primary antibodies to provide a negative control 
against non-specific binding and for background correction.  The following day 
samples were washed three times for 10 minutes with 1x TBS.  FITC conjugated 
secondary anti-rabbit and anti-mouse antibodies (1:1000) in 1.0% goat serum were 
applied to the samples for 60 min, followed by three washes with 1x TBS containing 
0.1% NP-40.  DAPI (1:1000) was diluted in TBS and applied for 10 min.  Following 
incubation, slides were washed four times with 1x TBS containing 0.1% NP-40.  
Fluorescent images were acquired with a Zeiss Axio microscope at 10x 
magnification.  Images were collected in 16 bit, black and white to maximize 
resolution.  False coloring was added by ImageJ.  At least three images of each 




Genomic DNA extractions and purification   
Approximately 1.0*106 cells were harvested and gDNA was extracted using 
DNeasy Blood & Tissue Kit (Qiagen; Hilden, Germany) according to the 
manufacturer’s protocol.  Samples were purified and concentrated using 100% 
ethanol and sodium acetate.  All gDNA samples were resuspended in DNase-free 
water to a concentration of 15-25 ng/µL.  Purity was assessed using a Nanodrop 
2000c and deemed acceptable with 260/280 ratio’s between 1.7 - 1.8.   
 
HTT amplification for fragment analysis   
We chose to test these potential biomarkers against 2 unknown fibroblast 
lines, each having one parent affected by HD but never having been tested for 
confirmation of being affected by HD.  Homemade primers were synthesized by 
Integrated DNA Technologies.  The forward primer sequence was 5’-
ATGAAGGCCTTCGAGTCCCTCAAGTC-3’, with a carboxyfluorescein at its 5’ 
end, and the reverse was 5’-CGGTGGCGGCTGTTGCTGCTGCTGCTGCTG-3’ 
(Jama et al., 2013).  Melting temperatures were 63.5°C and 72.7°C respectively.  
Amplification reactions were run in 20 µL volumes and contained the following 
components; 1X FailSafe Premix J (Epicenter, Madison, WI), 1U of Platinum® Taq 
DNA Polymerase High Fidelity (Life Technologies), 1.0 µL of 20-25 ng/µL gDNA 
sample, and 0.5 µM of each primer.  PCR conditions were as follows; 95.0°C for 1 
min hot start/initial denaturation, followed by 35 cycles of 94.0°C for 1 minute, 
64.0°C for 1 minute, 72.0°C for 2 minutes, and a final extension of 15 minutes at 
72.0°C.  Each cell line had 10 µL loaded into a 2% w/v agarose gel for 
electrophoresis separation.  Confirmation of correct amplicon size was visualized 
with ethidium bromide on a UV transilluminator (260 nm).  After size confirmation 
with agarose gel, 1.0 µL of each sample was combined with 1.0 µL of Mapmarker 
1000 internal size standard (BioVentures Inc., Murfreesboro, TN) and 9.0 µL Hi-Di 
Formamide (Life Technologies).  Just before sample loading of 10 µL onto capillary 
electrophoresis plates, each sample was heated to 95.0°C for 2 minutes for 
denaturation and then immediately placed on ice for 2 minutes.  Capillary 
electrophoresis fragment analysis was conducted on an Applied Biosystems 3130 
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Genetic Analyzer (Applied Biosystems) with 36 cm arrays and POP-7™ Polymer-
CG (Applied Biosystems).  Electrokinetic injection of samples was initiated with 12 
kV for 16 sec, and then electrophoresed at 15 kV for 1200 sec at 60°C.  Raw data 
was analyzed using GeneMarker Version 2.6.4 software (SoftGenetics LLC, State 
College, PA) (Jama et al., 2013).  We conducted amplified fragment length 
polymorphism analysis using optimized macros for TNR expansion calling and 
labeling.   
 
Bisulfite conversion and meCpG analysis   
Genomic DNA samples were treated to obtain bisulfite conversion using the 
EpiTect Fast Bisulfite Kit (Qiagen) according to the manufacturer’s protocol.  In 
each reaction, 2 µg of gDNA was converted for each sample.  Genomic DNA 
quality was determined by 1.5% agarose gel electrophoresis.  Homemade primers 
were created to evaluate methylation patterns approximately -500 base pairs 
upstream of the respective genes’ coding start sight using MethPrimer Software 
(Li and Dahiya, 2002).  Oligonucleotide primers and Tm’s are listed in Table 5.  
PCR amplification of bisulfite treated gDNA was conducted using 1U of Platinum 
Taq DNA Polymerase High Fidelity (Life Technologies), 500 ng of gDNA template, 
1X High Fidelity Buffer, 0.4 mM of each dNTP, 2 mM MgSO4, 0.5 µM of each 
forward and reverse primer, 2 mM betaine, with nuclease-free water in 20 µL 
reactions.  We utilized a touch-up PCR cycling protocol where the annealing 
temperature was gradually increased after the first and second set of 5 cycles, with 
annealing temperatures increasing from 53°C to 56°C and finally 60°C for the 
remaining 30 cycles.  PCR cycling conditions were as follows; 95°C for 1 min hot 
start, followed by a touch-up protocol with increasing annealing temperatures for 
1 min, 72°C for 1 min for 40 total cycles.  A final extension of 10 minutes at 72°C 
was applied at the end.  Correct amplicons were assessed using gel 
electrophoresis on a 1.5% agarose gel.  Appropriate bands were extracted using 
QIAquick Gel Extraction Kit (Qiagen).  Each extracted amplicon was into the pCR4-
TOPO TA vector with the TOPO TA cloning kit for sequencing (Thermo Fisher).  
Cycle sequencing of fragments was conducted using the M13 forward and reverse 
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primers provided with the kit.  Methylation analysis and representation was 
conducted using online software Methylation Plotter (Mallona et al., 2014). 
 
Data analysis and statistical significance   
Messenger RNA expression of fibroblasts was independently conducted 
three times with each experiment sub-sampled in triplicate.  Raw cycle-threshold 
(Ct) values of each sub-sample were averaged to give one mean Ct.  Mean Ct 
values of tested genes was normalized against the housekeeping gene ACTB to 
determine ΔCt values.  Each gene ΔCt value was then normalized to wild-type 
fibroblast sample GM-02187 to determine ΔΔCt’s.  Fold expression was decided 
by 2-ΔΔCt.  Error bars were determined using the standard deviation of experimental 
triplicate variation between fold-expression.   
 Fluorescent image analysis was conducted using ImageJ software.  ImageJ 
provided unbiased automatic background subtraction for each channel.  Cell 
fluorescence was determined by multiplying the total area of the image by mean 
background of the image, then subtracted from integrated density.  The cell 
fluorescence of each image was then divided by the number of complete nuclei in 
the image to give the corrected total cell fluorescence (CTCF).  Mean CTCF is 
represented graphically as normalized values to the mean CTCF of wild-type 
fibroblast sample GM02187 (Wt-1).  Error bars represent the standard deviation of 
individual CTCF obtained in each image.    
 Analysis of HTT gene expansion raw data was conducted using 
GeneMarker software (State College, PA).  Macro’s for bin calling were customized 
using gDNA samples obtained from Coriell Cell Repositories and were graciously 
created by Mohamed Jama (University of Utah).  The macros created algorithms 
that binned the most prominent fluorescence peaks of a specific wavelength within 
a -3.0 to +3.0 base pair range, standardized by an internal size standard 
fluorescence ladder of a specific wavelength.   
 Data for multiple comparisons were subjected to ANOVA statistical analysis 
with Dunnett’s test post-hoc to determine statistically significant differences 
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between samples.  Two way analysis was conducted using student t-tests.  





















































































































































































































































































































APEX1, BRCA1, and RPA1 deficient gene expression identified in HD and 
unknown fibroblasts 
 To investigate the wide spread cellular effects of mHtt on DNA repair gene 
expression, we extracted mRNA from confirmed HD fibroblasts and unknown 
fibroblasts.  A total of 7 primary fibroblast lines were obtained from Coriell cell 
repositories, with 2 unaffected samples (GM02187 and GM02153), 3 previously 
confirmed HD-affected samples (GM02079, GM03621, and GM03868), and 2 
unknown samples (GM02079 and GM04022).  Cell lines are in figures are 
designated “HD-n” if they were previously confirmed to have HD.  Cell lines 
designated “pHD-n” are cell lines in which they have a 50% probability of being 
affected by HD, but were initially unknown to us.  Gene expression analysis 
revealed statistically significant down-regulation of all three genes in all HD-
affected and unknown fibroblast lines (Fig. 10).  The mRNA levels presented are 
in relation to control sample Wt-1 (GM02187), with gene expression levels of 
targeted genes arbitrarily set as 1.   
 In addition, we conducted immunocytochemistry of all fibroblast lines and 
protein content reflected the mRNA reduction (Figs. 11-14).  Corrected total cell 
fluorescence (CTCF) revealed that protein levels in pHD-1 and pHD-2 samples 
were approximately 23% of APEX1, 22% of BRCA1, 8% of RPA1 and 32% of 
RPA3 (Fig. 15), and 54% of APEX1, 35% of BRCA1, 46% of RPA1, and 36% of 
RPA3 (Fig. 16) respectively.  Protein levels are relative to the lowest expressing 
wild-type fibroblast sample.  These data demonstrate that DNA repair components 
is significantly decreased in HD fibroblast samples, possibly having consequences 
on DNA repair pathways to efficiently address lesions and adducts created during 









Fig. 10.  DNA repair deficiencies in multiple HD fibroblast cell samples.  APEX1, 
BRCA1, RPA1 and RPA3 expression in wild-type (Wt-1), potential-HD-affected 
(pHD), and HD-affected (HD) fibroblasts.  Using TaqMan® Gene Expression 
Assays, we identified HD DNA repair mRNA down-regulation of APEX1, 
BRCA1, RPA1, and RPA3. Gene expression is determined by the (2-ΔΔCt) of the 
mean of each independent triplicate.  Error bars represent the standard 
deviation of the mean between replicate samples.  Each tested gene showed 
significant decreases in expression for all HD and pHD cell lines, relative to the 
wild-type sample.  Statistical significance was determined using a two-tailed, 
homoscedastic T-Test (*p<0.001).  Gene expression is normalized to wild-type 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 15.  Immunofluorescence measurement of protein deficiencies in pHD-
1 fibroblast cell line.  Measuring cell fluorescence, semi-quantitative protein 
analysis of pHD-1 revealed down-regulation of investigated DNA repair 
proteins.  Total fluorescence of cell area was measured and then normalized 
against the wild-type sample.  Error bars represent the standard deviation of 
the mean corrected total cell fluorescence.  Statistical significance was 












































Fig. 16. Immunofluorescence measurement of protein deficiencies in pHD-2 
fibroblast cell line. Measuring cell fluorescence, semi-quantitative protein 
analysis of pHD-2 revealed down-regulation of investigated DNA repair proteins.  
Total fluorescence of cell area was measured and then normalized against the 
wild-type sample.  Error bars represent the standard deviation of the mean 
corrected total cell fluorescence.  Statistical significance was determined using 





































Unknown fibroblast samples are affected by HTT expansion 
 Two cell lines were purchased from Coriell Cell Repositories that had a 50% 
probability of being affected by HD (pHD-1 and pHD-2), but were not previously 
confirmed as either normal or affected.  As positive controls we obtained 6 gDNA 
samples from various HD-affected and wild-type characterizations.  These chosen 
positive control gDNA samples have previously been tested in multiple laboratories 
and were sequenced to confirm CAG repeats (Data not shown).  To determine HD 
status of unknown fibroblast lines we conducted capillary electrophoresis fragment 
analysis on all samples (Figs. 17A-G).  Characterization of lines are summarized 
below (Table 6).  Both unknown fibroblast lines GM02191 (pHD-2) and GM04022 
(pHD-1) were confirmed to be affected by HD.  Fragment analysis revealed that 
the HTT fragment length varied based upon the pathogenic (CAG)n expansion.  
Examination of the fragments revealed unknown samples GM02191 containing 
17/42 (CAG) repeats and GM04022 containing 18/44 (CAG) repeats at the initial 
time of capillary electrophoresis.  Combined with data identifying APEX1, BRCA1, 
RPA1 and RPA3 down-regulation, this confirmation of unknown samples being 
affected by HD identifies therapeutic biomarkers, as well as a possible alternate 
means for HD diagnosis.   
 Interestingly, we witnessed TNR instability in previously characterized HD 
samples HD-1 and HD-2.  Previously Coriell Cell Repositories reported HTT gene 
characterization of HD-1 as containing 21/44 (CAG)’s and HD-2 containing 18/44 
(CAG)’s.  Our initial characterization was conducted after 10 population doublings 
and revealed HTT expansions of 21/45 and 18/48, respectively.  No instability was 
detected in either wild-types samples Wt-1 or Wt-2 after identical population 










Fig. 17. Fragment analysis characterizing of all fibroblast lines.  Using triple-
primed polymerase chain reaction in combination with capillary electrophoresis, 
UNK fibroblast samples show HD (CAG) expansions within the gene.  Wild-type 
samples used in our experiments are (A) Wt-2 GM02153 with 16/32 (CAG)’s, 
and (B) Wt-1 GM02187 with 17/23 (CAG)’s.  HD-confirmed cell lines (C) HD-1 
(GM02079) contain 21/45, (E) HD-2 (GM03621) contain 18/60, and (G) HD-3 
(GM03868) contain 17/48.  Cell lines (D) pHD-2 (GM02191) and (F) pHD-1 
(GM04022) were purchased from Coriell Cell Repositories as described as 
“Unknown – 50% probability of being affected”.  Fragment analysis reveals both 
unknown cell lines are in fact HD-affected, with alleles containing 17/42 and 
18/44, respectively.  Interestingly, TP-PCR also shows TNR instability with a 
subpopulation of gDNA extracted from HD each sample, relative to their 
previously published expansions by Coriell.  GM02191 shows expansions up to 
45 (CAG)’s in the affected allele, and GM04022 show expansions up to 47 
(CAG)’s.  Alleles containing (CAG)>35 are diagnosed HD.  ROX1000 MapMarker 
dye serves as an allelic ladder and is indicated by the red peaks. 
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APEX1, BRCA1 and RPA1 gene expression is affected by 5-azacytidine 
treatments, but not by trichostatin-A 
   We next wanted to identify the mechanism causing down-regulation in the 
identified DNA repair genes.  As no previous DNA repair gene mutational events 
have been associated with HD, we hypothesized that epigenetic regulators could 
be a primary cause of the observed down-regulations.  To test for the involvement 
of histone acetylation and DNA condensation as a primary regulator we treated 
pHD-1 and pHD-2 samples with 5 µM trichostatin-A (TSA), a potent global de-
acetylase inhibitor for 24 h.  For controls, the cells lines were treated with 0.01% 
v/v DMSO for identical time treatment.  Quantitative PCR revealed no significant 
DNA repair gene change in both pHD-1 (Fig. 18A) and pHD-2 (Fig. 18B) in 
response to TSA treatments, with the vehicle control showing minor fluctuations 
relative to an untreated control sample.   
Similar to TSA treatments, we chose to investigate the effects of 5-
azacytidine to determine possible methylation involvement in expression.  pHD-1 
and pHD-2 samples were seeded and cultured in the presence of culture media 
supplemented with 10 µM 5-azacytidine for 120 h.  Media was replaced daily with 
freshly made 5-azacytidine to optimize passive demethylation during DNA 
synthesis and to facilitate the removal of toxic products.  After 5 days, mRNA was 
collected and subjected to qPCR to evaluate gene expression.  HD samples 
GM02191 and GM04022 showed significant up-regulation of APEX1, BRCA1, and 
RPA1 (Fig. 19A, 19B). Interestingly, HD sample GM02191 did not show a change 
in the expression of RPA3 mRNA, however.  To further confirm expression, ICC of 
each cell line was conducted (Fig. 20A, 20B).  Corrected total cell fluorescence of 
ICC validated gene up-regulation, with pHD-1 showing increases in APEX1, 
BRCA1, RPA1, and RPA3 (Fig. 21A) with fold changes of 1.8, 1.4, 1.2, and 1.4 
respectively.  pHD-2 showed similar fold increases with 1.6, 1.5, 2.0, and 1.2 (Fig. 
21B).  Error bars are the SD of the mean CTCF of at least 3 images of each 
treated/untreated sample.  Statistical significance was determined using a two-
tailed, unpaired, parametric T-Test (*p<0.05, **p<0.01). Overall, these data 





azacytidine treatment.  Though no definitive research has shown that mHtt 
interacts with/ or causes hypermethylation, our results indicate that brief 
treatments of 5-azacytidine will up-regulate DNA repair gene expression in HD 
fibroblasts.  While we recognize that gene expression levels are not returned to 
wild-type expression levels, these data suggests that hypomethylation by 5-
azacytidine is at least partially responsible for the DNA repair gene deficiency we 
report in this work. 
 
Differential methylation patterning in APEX1 promoter in HD fibroblasts 
To confirm 5-azacytidine treatments caused passive hypomethylation, we 
conducted bisulfite sequencing analysis of ~500 base pairs upstream of the 
APEX1 transcriptional start site.  We also included ~75 base pairs downstream 
from the start site.  gDNA from 5-azacytidine treated pHD-1 (T-pHD-1), treated 
pHD-2 (T-pHD-2), untreated pHD-1 (U-pHD-1), and untreated pHD-2 (U-pHD-2) 
underwent a bisulfite reaction to replace all cytosine’s that were not methylated.  
As well, samples from 5-azacytidine treated Wt-1 (T-Wt-1) and untreated Wt-1 (U-
Wt-1) samples were also included.  Samples were analyzed using ABI Genetic 
Analyzer 3130 to determine the presence of meCpG sites.  Treated Wt-1 (T-Wt-1) 
sample and untreated Wt-1 (U-Wt-1) bisulfite sequencing of the promoter revealed 
no methylation in the -500 to +75 base pair region relative to the transcriptional 
start site (Figure 22).  Treated samples T-pHD-1 and T-pHD-2 showed no 
methylation patterning, which is expected after treatment of DNA hypomethylation 
agent 5-azacytidine.  Untreated samples U-pHD-1 and U-pHD-2 revealed 
differential methylation patterns relative to U-Wt-1.  U-pHD-1 revealed methylation 
sites at base pairs -437 and -28.  U-pHD-2 showed methylated CpG’s at base pairs 
– 435, -427, -417, -412, -138, -68, -28, and -7, upstream of the transcriptional start 
sight.  Not only does these data confirm that 5-azacytidine treatments caused 
direct hypomethylation through passive cell replication, but this also brings to light 
the differential methylation patterns seen in HD-fibroblasts.  This differential 
methylation in the promoter region of APEX1 elucidates the possible cause of gene 




























































ity No Treatment (pHD-2)DMSO (pHD-2)
TSA Treated (HD2)
Fig. 18. DNA repair gene mRNA expression with trichostatin-A treatment.  (A) 
pHD-1 fibroblasts and (B) pHD-2 fibroblasts were exposed to 5 µM trichostatin-
A for 24h.  As well, a separate sample of cells was treated with 0.01% v/v of 
DMSO as a vehicle control. Gene expression is determined by the mean (2-ΔΔCt) 
of each independent replicate, relative to the untreated controls. Each tested 
gene showed alarming decreases in expression for the pHD-1 and pHD-2 
fibroblast samples in response to trichostatin-A treatment.  Gene expression is 
normalized to the same untreated-HD fibroblast gene expression. Error bars 
represent the standard deviation of the mean.  Statistical significance was 





Fig. 19. DNA repair gene mRNA expression with 5-azacytidine treatment.  (A) 
pHD-1 fibroblasts and (B) pHD-2 fibroblasts were exposed to 10 µM 5-
azacytidine for 120 h.  Media was changed daily to ensure adequate amounts 
for passive demethylation and removal of toxic products. Each tested gene 
showed significant increases in mRNA expression for the pHD-1 treated 
fibroblast line.  APEX1, BRCA1, and RPA1 showed statistically significant 
increases in pHD-2 treated cells. Gene expression is normalized to the same 
untreated-HD fibroblast gene expression.  Error bars represent the standard 
deviation of the mean.  Statistical significance was determined using a two-
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Fig. 20. Immunocytochemistry of DNA repair genes in pHD-1 cells treated with 
10 µM 5-azacytidine.  pHD-1 (A) and  pHD-2 (B) fibroblast lines were exposed 
to 10 µM 5-azacytidine for 120 h, alongside untreated controls (right and left 
columns respectively).  ICC images show slight increases in fluorescence of 
DNA repair genes. Nuclei staining was conducted with DAPI.  Images were 
acquired using a Zeiss Axio microscope with a short-working distance 20X 
objective.   


























Untreated 10 µM 5-azacytidine 



























































































Fig. 21. Immunofluorescence measurement of DNA repair gene protein 
expression with 5-azacytidine.  Protein quantity was determined using 
corrected total cell fluorescence of the collected cell.  Analysis revealed 
statistically significant up-regulation of APEX1 for 5-azacytidine treated pHD-1 
(A)   fibroblasts.  pHD-2 (B) fibroblasts treated with 5-azacytidine showed 
statistically significant up-regulation of APEX1 and BRCA1.  Bars represent the 
mean CTCF of at least three pictures.  Error bars represent the standard 
deviation of the mean.  CTCF is relative to the untreated sample. Statistical 
significance was determined using a two-tailed, unpaired, parametric T-Test 






























































































































































































































































































































































































































































































































































Intermittent 5-azacytidine treatments induces TRN stability in the HTT gene 
 Cell lines pHD-1 and pHD-2 were plated in T-75 flasks and treated 
intermittently with 10 µM 5-azacytidine over the course of 35 days to reach four 
population doublings.  Genomic DNA samples were taken of pHD-1 and pHD-2 
samples at the initial split before the treatment began, and at the end of the 35 day 
time-frame.  In parallel to the treated samples, we passaged a sub-population of 
each sample as a non-treated control.  pHD-1 sample began the treatment 
regimen with HTT gene affected allele containing 43 (CAG)’s, with a small 
population of cells showing expansions in the affected allele up to 44 and 45 (Fig. 
23).  At the end of treatment schedule, the untreated control pHD-1 sample showed 
expansions of predominantly 44, with a small population of 45 (CAG)’s.  The pHD-
1 sample treated intermittently with 5-azacytidine showed (CAG) repeats of 43, 
with a small population of 44.   Similar results were witnessed in sample pHD-2.  
Initial expansion of the affected allele was characterized as having predominantly 
41 (CAG)’s (Fig. 24).  At the end of the treatment cycles, the untreated pHD-2 
sample showed predominantly 42 (CAG)’s with instability within the population up 
to 45.  The treated pHD-2 sample showed the majority of cells had 41 (CAG)’s, 
with a small subset of the cell population having 42.  Representation of both alleles 
















Fig. 23. Fragment analysis revealing 5-azacytidine induced TNR stability in 4 























Fig. 23. Continued.  pHD-1 fibroblast cell lines were treated with 10 µM 5-
azacytidine periodically over the course of 35 days.  The top chromatogram 
of each image represents the (CAG) expansions at day 0.  The middle 
chromatogram represents the (CAG) expansion of the untreated control at day 
35.  The bottom chromatogram shows the (CAG) expansion of the 5-
azacytidine treated samples.  pHD-1 fibroblasts show beginning and treated 
samples with (CAG) repeats of 17/43, with a small population of cells showing 
expansions up to 44-45.  Untreated pHD-1 show (CAG) an HD expansion of 




Fig. 24.  Fragment analysis revealing 5-azacytidine induced TNR stability in 4 























Fig. 24.  Continued.  Sample pHD-2 cell were treated with 10 µM 5-azacytidine 
periodically over the course of 35 days.  The top chromatogram of each image 
shows the (CAG) expansions at day 0.  The middle chromatogram represents 
the (CAG) expansion of the untreated control at day 35.  The bottom 
chromatogram shows the (CAG) expansion of 5-azacytidine treated samples.  
Treated pHD-2 fibroblasts shows (CAG) repeats of 17/41, similar to the starting 
sample.  Untreated pHD-2 cells show minor TNR instability within the gene 
with expansions predominantly 17/42, with the affected allele showing a small 




Fig. 25.  Chromatograph showing entire triplet-primed PCR amplicons of 5-
azacytidine induced TNR stability in 4 population doublings in HD fibroblasts.  
The top chromatogram of each image represents the (CAG) expansions at day 
0.  The middle chromatogram represents the (CAG) expansion of the untreated 
control at day 35.  The bottom chromatogram shows the (CAG) expansion of 
the 5-azacytidine treated samples.  (A) pHD-2 treated with 5-azacytidine shows 
(CAG) repeats of 17/41.  Untreated pHD-1 show minor TNR instability with 
predominantly 17/42, with the affected allele showing a small population of cells 
expanding up to 45.  (B) pHD-1 fibroblasts show the initial and treated samples 
with (CAG) repeats of 17/43, with a small population of cells showing 
expansions up to 44-45.  Untreated pHD-1 show (CAG) an HD expansion of 




































































Fig. 25.  Continued. 
CAG 17 CAG 43 
CAG 18 CAG 44 




In an effort to elucidate the pathogenetic cause of HD (CAG) expansions, 
we investigated DNA repair gene expression, known effectors of TNR instability.  
The mhtt protein produced by the expanded TNR region of exon 1 in the HTT gene 
interacts nonspecifically with many unintended targets.  The resulting interaction 
leads to cellular dysfunction on multiple levels including transcriptional 
dysregulation, mitochondrial dysfunction, altered vesicular transport, ROS 
defense, abnormal endocytosis and secretion, and increased apoptosis.   
 We initially sought to determine if HD-affected fibroblasts suffer from 
decreased DNA repair gene expression, possibly contributing to TNR instability.  
Through qPCR and quantification of ICC, we found consistent decreases in 
APEX1, BRCA1, RPA1, and RPA3 in multiple HD fibroblast cell samples.  
Interestingly, using the decrease gene expression levels witnessed in HD-
confirmed cells, we successfully identified two possible samples as being affected 
by HD (pHD-1 and pHD-2).   Furthermore, protein quantification resembled the 
decreased mRNA levels.   
Having seen consistent expression levels in 5 unrelated, HD-confirmed 
samples, we initially ruled out the possibility of genetic mutations and began to 
explore probably epigenetic causes.  The unintended aggregation of mHtt to other 
targets is extensive, and has been thoroughly reported to inhibit gene expression 
because of failure to acetylate histone complexes, thus allowing strand access.  
We first examined the effect of trichostatin-A (TSA) on selected DNA repair gene 
expression.  TSA has been shown to inhibit histone deacetyltransferase activity, 
thus allowing histone tails to remain acetylated, relaxing the DNA strand, which in 
turn allows successful recruitment of transcriptional or replication machinery.  
Neither sample showed increases with TSA treatment.   
While little evidence exists that implicates HD in methylation dysfunction, 
our next step was determine the possibility that differential methylation patterns 
could be involved or that a hypomethylation agent would have off-target effects.  
Using passive, demethylation, we treated cells with the cytidine analogue, 5-
azacytidine.  Samples treated with 10 µM 5-azacytidine for 120 h revealed that 
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gene expression levels of the selected DNA repair genes were up-regulated in HD 
fibroblasts.  To further investigate the possibility of methylation-involved 
pathogenesis of HD, we wanted to determine the effect of 5-azacytidine on HD 
fibroblasts over prolonged, intermittent exposure.  Intriguingly, both fibroblast lines 
exposed to 5-azacytidine over 4 population doublings retained the initial (CAG) 
expansion as they had begun, with pHD-1 maintaining predominantly 18/43, and 
the untreated control expanding to 18/44.  Similarly, pHD-2 treated fibroblasts 
started and retained (CAG) 17/41, with the control ending at 17/42.  While the 
treated concentration of 10 µM was used, a logical course of action is to decrease 
this concentration below LC95 concentrations and determine its’ affect over 
extended treatment periods. 
Our results indicate the production of mhtt protein directly or indirectly inhibit 
the regulation of genes necessary for maintaining genome integrity.  The role of 
BRCA1 in DNA damage is extensive, with involvement in double-strand breaks in 
DNA and mismatch repair, as well as p53, an upstream activator of DNA repair, 
initiator of apoptosis, and regulator of the cell cycle (Lin and Benchimol, 1997; 
Morgan and Kastan, 1997; Ouchi et al., 1998; Schwartz and Rotter, 1998).  
BRCA1s’ direct interaction with mismatch repair proteins, and its’ interaction with 
BRCA1-associated Ring domain protein (BARD1) suggest that it plays a global 
role in DNA damage repair (Wang et al., 2001).  It has also been shown that 
BRCA1-deficient cells, Rad51 complexes fail to assemble, severely impairing DNA 
repair (Spiro and McMurray, 2003).  There has been very few reports of BRCA1 
being involved in HD exacerbation or vice versa.    
Replication protein A (RPA) is a heterotrimeric (14-, 32-, and 70-kDa 
subunit), single-stranded binding protein, vital for the stability of single-stranded 
DNA during DNA metabolic processes, including transcription, replication, cell 
cycle advancement, and DNA damage response (Binz et al., 2004; Broderick et 
al., 2010; Chen and Wold, 2014).  RPA70 and RPA14, together RPA32, create an 
RPA complex, essential to stabilize ssDNA stands, thus preventing premature, 
intra- and inter-strand re-annealing (Wold, 1997).  It has been shown that 
prolonged overexpression of SSB in E.coli (RPA homolog) induce (CAG)·(CTG) 
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stability (Andreoni et al., 2010).  We logically concluded that the reduction in 
ssDNA stability would allow unintentional secondary structure formation.  Bulky 
adduction creation results in abnormal spatial patterning, which has shown to 
hinder appropriate DNA damage responses (Goula et al., 2009; Goula et al., 2012; 
Jeon et al., 2012a).   
Base damage is the most prevalent DNA lesion in the human genome, 
occurring approximately 104 times in one cell within 24 h (Lindahl and Nyberg, 
1972).  DNA base lesions can be caused by both environmental cellular stressors 
and endogenous factors, resulting in spontaneous hydrolysis (Hoeijmakers, 2007).  
These apurinic/apyrimidinic (AP) sites are addressed with base excision repair 
pathways that involve removal of the damaged base, cleavage of the 
phosphodiester backbone, replacement of the proper base, and eventual ligation 
of the DNA strand.  Specifically, APEX1 is responsible for the backbone cleavage 
on the 5’ site of the AP site.  Previous reports have shown that AP sites within 
(CAG) hairpins are generally resistant to APEX1 incision in constructed domains, 
where AP sites in fully annealed (CAG)/(CTG) sequences are corrected effectively 
(Li et al., 2014).  More importantly, the N-termini of APEX1 contains 
reduction/oxidation properties known to maintain optimal transcriptional activity 
and DNA binding affinity (Bhakat et al., 2009; Li et al., 2012; Luo et al., 2008; Ono 
et al., 1995; Ramana et al., 1998; Singh and Englander, 2012).  Furthermore, 
emerging research is also linking APEX1 and base excision repair pathways to 
indirect demethylation of the genome, through repair of mCyt 5’ to oxo-guanines 
(Endutkin and Zharkov, 2015; Santos et al., 2013).  In relation to HD, a double 
dose effect of inefficient cleavage of HTT gene hairpins by APEX1 and decreased 
expression could account for the progressive TNR expansions witnessed as well 
as the response to 5-azacytidine and the TNR stability reported.   
We further identified that 5-azacytidine treatment of HD fibroblasts up-
regulates investigated DNA repair gene expression and protein synthesis.  As of 
now, little evidence exists that mhtt directly affects or interacts with epigenetic 
methylation patterning.  However, it is worth noting that there is evidence of 
extensive changes in methylation patterns in HD, explicitly involving sequence 
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specific DNA-binding motifs for certain transcription factor families (Ng et al., 
2013).  As well, we also witnessed TNR stability in HD-affected fibroblast cells with 
the intermittent exposure to 5-azacytidine.  Our results indicate that 5-azacytidine 
can marginally rescue the DNA repair gene deficiencies we witnessed here, and it 
stabilizes HTT gene instability.  This suggests that pharmaceutical intervention is 
possible in restricting the TNR instability, thus decreasing the genetic anticipation 
experienced in HD. 
In conclusion, our identification of endogenously down-regulated DNA 
repair genes in HD-affected fibroblasts begs the questions of (1) how does mHtt 
affect DNA repair gene expression, and (2) is the DNA repair gene expression 
witnessed further confounding TNR instability experienced in HD, thus allowing 
genetic anticipation to progress unregulated.  While there is overwhelming 
evidence showing HD and DNA repair as being effectors of each other, no 
comprehensive model has been determined to clearly explain TNR instability in 
HD or pathogenesis of sporadic HD.  Importantly, the identification of APEX1, 
BRCA1, RPA1 and, RPA3 down-regulation in HD can possibly provide therapeutic 
targets and provide as biomarkers for disease progression or treatment success.  
Our observations of gene up-regulation in response to 5-azacytidine infers that the 
interference of mHtt (or loss of wild-type Htt) is widespread cellularly, and that we 
are still determining second and third degree down-stream effects.  Our 
observations revealing intermittent treatment of 5-azacytidne and it’s’ up-
regulation of DNA repair genes raises the possibility that mHtt might be interfering 
with DNA methylation epigenetics.  Any dysfunction of methylation pattern 
maintenance caused by mHtt would clearly alter physiological epigenetics and 
would have repercussions long before HD neuronal dysfunction presents, 
especially when considering the extensive involvement that methylation plays on 
neurogenesis (Covic et al., 2010; Sun et al., 2011; Szulwach et al., 2010).   
Importantly, the identification of APEX1, BRCA1, RPA1 and, RPA3 down-
regulation in HD can possibly provide therapeutic targets and provide as 
biomarkers for disease progression or treatment success.   While the passive 
demethylation by cell division doesn’t address mitotically inactive cells (medium 
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spiny neurons), the stabilization of the (CAG) expansion in exon 1 of the HTT gene 
over 4 population doublings begs the possibility that controlling TNR instability and 
preventing HD-associated genetic anticipation might involve methylation 































HUNTINGTON’S DISEASE INDUCED PLURIPOTENT STEM CELLS SHOW 
ENHANCED LEVELS OF DNA REPAIR GENE EXPRESSION AND 
TRINUCLEOTIDE REPEAT INDUCED STABILITY 
 
Introduction 
Huntington’s disease (HD) is a genetically inherited neurodegenerative 
disease.  HD is caused by an expansion of cytosine-adenine-guanine (CAG) 
trinucleotide repeats (TNR) in exon 1 of the HTT gene.  The disease-causing 
pathogenic TNR region is prone to instability, evidenced by somatic tissue 
mosaicism and intergenerational differences during disease transmission.  As of 
yet, there is no cure for HD. At best, clinicians temporarily address disease 
symptoms during early disease onset, but ultimately abandon pharmacological 
intervention as HD progresses.  Currently, there is extensive research on treating 
symptomatic progression of HD, with the most promising treatments involving cell-
replacement therapies, specifically with the use of induced pluripotent stem cells 
(iPSCs).    While the field of iPSC is relatively young, much emphasis is being 
placed on mapping the proteome and identifying differential characteristics unique 
to iPSC, relative to other more studied cell types.  This is especially true in the 
context of diseased-iPSC models.  
Reprogramming somatic, terminally differentiated cell types into pluripotent 
cell types requires simultaneous infection of transcription factors Oct4, Sox2, 
cMyc, and Klf4.  These four transcription factors together have been referred to as 
the “Yamanaka factors”, after the discovering scientist, Dr. Shinya Yamanaka 
(Takahashi et al., 2007).  It is fairly recognized that the Yamanaka factors results 
in the greatest efficiency and is thus the most conventional method of inducing 
pluripotency.  There are other combinations of transcription factors that can be 
used to induce pluripotency, being Oct4, Sox2, Nanog, and Lin28A.  Unfortunately, 
the reprogramming process is extremely harsh on somatic cells, with 
reprogramming-efficiencies only reaching ~0.01%-0.1% of total cells undergoing 
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successful reprogramming to pluripotency.  The extremely low percentage of 
pluripotent cells during reprogramming is due to the fact that two of the four 
transcription factors used in this process are oncogenes, namely cMyc and Klf4.  
These genes have dramatic effects in the cell.  Interestingly, they act in positive-
feedback loops on themselves and on each other.  Also, they reactivate human 
telomerase reverse transcriptase, or TERT, the gene responsible for telomere 
maintenance.  It is this reactivation of telomerase that allow cell division 
unrestricted by the Hayflick limit.  Further, reprogramming to pluripotency has 
shown dramatic epigenetic changes in cells.  As mentioned previously, two of the 
major epigenetic regulatory mechanisms is methylation patterning and histone 
modification.  While much research is still needed, data shows that a combination 
of the Yamanaka factors change epigenetic print the cell had previously acquired 
(Hewitt et al., 2011; Sullivan et al., 2010; Vaskova et al., 2013).  We wanted to 
determine the effect that pluripotency reprogramming, and by extension the global 
epigenetic shift that occurs, would have on DNA repair gene expression in cells 
that have dysregulated pathways as the result of epigenetic regulation.    
While iPSC hold great promise for personalized cellular replacement 
therapies, a more immediate use for iPSCs is in the modeling of genetic diseases. 
For instance, one of the most recognized characteristics of iPSCs is the global 
epigenetic changes involved in reprogramming.  Multiple studies have identified 
differential regulation of epigenetic regulatory elements and patterns in normal and 
diseased cells (Carey et al., 2011; Hewitt et al., 2011; Leung et al., 2014; Vaskova 
et al., 2013).  Another key finding is that analysis of Affimetrix data has so far 
revealed more than 2000 differentially expressed genes in wild-type iPSCs and 
ESCs, relative to human neonatal foreskin fibroblasts (Cai et al., 2015).  Other data 
has revealed that increased levels of endogenous reactive oxygen species (ROS) 
exist in iPSC, and that enhanced levels of DNA repair gene expression exist in 
response to the increased ROS levels (Fan et al., 2011).  It is no surprise that the 
very nature of pluripotency requires different levels of mechanism involvement, 
and the data reporting dramatic differences in gene expression supports this.  In 
the context of TNR instability and pluripotent cell-states, current data is extremely 
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limited.  However, one study involving Friedreich ataxia (FRDA), another 
neurodegenerative disease caused by repeat expansions, revealed disease-
associated tandem repeat expansions in FRDA-iPSCs, and that DNA mismatch 
repair protein expression was elevated (Du et al., 2012).    Unfortunately, this 
knowledge is in its infancy and much research still must be done to 
comprehensively understand mechanisms involving TNR instability and targeted-
cell differentiation in vitro and in vivo.  Of equal importance, HD-iPSC models have 
enabled researchers to study the pathogenicity of HD in disease-affected cell 
models, striatal medium spiny neurons.  In the short time iPSC-reprogramming has 
been available, research using HD-iPSCs showed that pluripotent cells affected by 
HD show differentially expressed proteins involved in oxidative stress and 
apoptotic responses (Chae et al., 2012).  Research using HD-iPSCs has also 
elucidated that HD-iPSC models maintain the disease phenotype after 
differentiation and transplantation (Consortium, 2012; Jeon et al., 2012b; Juopperi 
et al., 2012).  Interestingly, transplanted human-HD-iPSC into the striatum of mice 
show delayed HD phenotypes, indicating mechanisms altered in reprogramming 
affect the onset of HD (Jeon et al., 2014).  These data confirm that altered 
expression exists during pluripotency, and further identifies stages in development 
where cellular mechanisms are altered, thus effecting cell response efficacy and 
genome integrity.  While extensive research is being conducted using iPSC 
models, only a small number of investigations are being conducted involving the 
pathogenic progression of HD using iPSC.  Thorough investigation of HD-iPSC, 
and cells derived from HD-iPSC is needed to create a comprehensive 
understanding the pathogenic TNR instability characteristic of HD and its 
progression.   
Of the research needed, iPSC models of HD are essential to understanding 
the pathogenic trinucleotide repeat (TNR) instability characteristic of HD 
progression and genetic anticipation. Perhaps the most important contribution that 
iPSC generation has in the research setting is the ability for a research team to 
characterize mechanisms affecting TNR instability during pluripotency, and then 
subsequently monitor mechanistic changes during targeted differentiation, while 
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systematically monitoring repeat changes.  Essentially, this experiment model 
allows for detailed TNR region analysis while mimicking developmental 
differentiation.  This is a key component to elucidating the mechanisms involved in 
somatic TNR mosaicism witnessed in HD.  Also, a highlight to using somatic 
reprogramming is that it allows for unlimited access to disease-specific cells, which 
would normally require extensive preparation and planning involving terminally-ill 
patients affected by HD.   
In this study, we begun to dissect DNA repair gene expression during 
developmental differentiation, thus laying a foundation for whole tissue differential 
analysis of genes involved in pathways effecting TNR instability.  Here we 
examined four DNA damage repair genes (APEX1, BRCA1, RPA1, and RPA3) 
that we have previously shown to be down regulated in HD cells.  Reprogramming 
of two HD fibroblast lines into iPSCs revealed expression of these genes had 
returned to similar levels as wild-type iPSCs.  Also, we report that HD-iPSC models 
undergo contraction-biased TNR instability in early stages, and then resort to 
stabilized regions in later stages.  Interestingly, further differentiation of HD-iPSC 
models into mesenchymal-like cells (MLCs) show slightly reduced levels of three 
of these DNA repair genes (BRCA1, RPA1, and  RPA3), but still maintained 
expression levels greater than levels in the native-cell state.   Further, HD-MLCs 
maintained TNR stability, showing no evidence of partial population expansions or 
contractions.  These findings suggest that DNA repair gene up-regulation assist in 
the maintenance of genome fidelity and that subsequent differentiation maintains 
increased repair gene expression relative to their parental lines, possibly inducing 
genomic TNR stability.    
 
Materials and methods 
Cell lines and cell culture   
Two human female HD fibroblast lines (GM02191 and GM04022) were 
previously purchased from Coriell Cell Repositories (Camden, NJ).  Two wild-type 
iPSC lines were previously generated and confirmed in our lab from breast-derived 
adipose stem cells (iPSC-WT1 and iPSC-WT2).  Fibroblast lines were cultured in 
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Dulbecco’s Modified Eagle’s Medium (DMEM) with Glutamax (Life Technologies, 
Carlsbad, CA), supplemented with 10% premium fetal bovine serum (Life 
Technologies) and 1% Antibiotic-Antimycotic (100x) (ABAM; Life Technologies).  
Induced-pluripotent stem cells lines were initially cultured in complete KnockOut 
DMEM/F-12 medium (Life Technologies).  Complete KnockOut Serum media 
(KOSR) was comprised of 20% KnockOut Replacement Serum, 1x MEM Non-
essential Amino Acids (Life Technologies), 10 ng/mL of Basic Fibroblast Growth 
Factor (Life Technologies), 55 nM β-mercaptoethanol, (Sigma Aldrich; St. Louis, 
MO) and 1% ABAM.  Confirmed iPSC lines were adapted to a feeder-independent 
protocol utilizing Essential 8 medium (E8) (Thermo Fisher Scientific; Waltham, MA) 
to minimize spontaneous differentiation.  MLCs were differentiated and cultured in 
mesenchymal stem cell media (MSC) comprised of DMEM with Glutamax, 10% 
fetal bovine serum, and 1% ABAM.  All cell lines were cultured and maintained at 
37°C in a humidified incubator with 5% CO2.  Use of human cell lines used was 
deemed exempt from IRB review, as it is impossible to identify cell donors. 
 
iPSC generation of HD cell lines 
To generate stable pluripotent cells, on day 0, 2.5-3*105 cells were infected 
using Sendai viral vectors expressing KOS (Klf4,Oct3/4, Sox2), c-Myc, and Klf4 
using the CytoTune™ –iPS 2.0 Sendai Reprogramming Kit (Life Technologies, 
Carlsbad, CA).  Cells were transformed according to the manufacturer’s protocol 
and lot specification (L2120009) of Sendai viral components, using a multiplicity of 
infection of 5:5:3.  On day 7 post-transduction, cells were plated onto irradiated 
murine-embryonic fibroblasts (iMEFs) (Globalstem; Gaithersburg, MD).  After 
confirmation of pluripotent-positive cells, colonies were manually split and 
passaged for expansion.  Upon initial expansion, all iPSC lines were adapted to a 
feeder-independent protocol using vitronectin coat plates at a concentration of 0.5 
µg/cm2 and were continuously cultured in E8 for the remainder of our experiments.  
iPSC lines adapted to E8 were passaged and split at ratios of 1:6 to 1:9 using 0.5 
µM EDTA in Ca- and Mg- phosphate buffered saline.  Media was replenished on 
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all pluripotent cell lines every 24 hours.  Generation of iPSCs using Sendai virus 
was conducted in compliance with IBC #13-021. 
 
Confirmation of successful iPSC reprogramming  
 Candidate iPSCs were initially selected for 30-32 days after infection 
with positive staining for TRA-1-81 (Stemgent; Lexington, MA) according to the 
manufacturer’s specifications.  After manually splitting 8-10 colonies that were 
positive for TRA-1-81 stain for expansion, the remainder of the colonies were 
analyzed for alkaline phosphatase (AP) activity using Stemgent Alkaline 
Phosphatase Staining Kit II (Stemgent) according to the provided protocol.  This 
further allowed us to distinguish stem cells from parental cells and iMEF feeder 
cells.  After successful expansion of candidate iPSCs, quantitative gene 
expression for pluripotency markers was determined using TaqMan Gene 
Expression Assays found in Table 7.   
 
Derivation of mesenchymal-like cells from iPSCs  
iPSC-MLC derivation was performed using previously published protocols 
(Kang et al., 2015).  Pure pluripotent colonies were isolated through manual 
selection and were brought to single-cell suspension in DMEM/F12 using 
StemPro® Accutase® Cell Dissociation Reagent (Thermo Fisher Scientific).   Cells 
were plated onto 0.1% gelatin (room temperature for 2 hours) in E8 for 20-24 
hours, and then media was replaced daily with MSC medium for two weeks.  
Sequential passaging was conducted using TrypLE Express Enzyme (Thermo 










Table 7  






















Expression Assay Number 
Pluripotency Marker     
 TERT Telomerase reverse transcriptase Hs00972656_m1 
 LIN28A Lin-28 Homolog A (C. elegans) Hs00702808_s1 
 KLF4 Kruppel-like factor 4 Hs00358836_m1 
 MYC Proto-oncogene c-Myc Hs00153408_m1 
 POU5F1 POU Class 5 homeobox 1 (Oct3/4) Hs00742896_s1 
 NANOG Nanog homeobox Hs04260366_g1 
Housekeeping Gene   
  ACTB β-Actin Hs99999903_m1 
α ACTB was the housekeeping gene used to normalize cellular expression. 
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Nucleic acid extraction and gene expression 
Over the course of multiple passages of newly transduced pluripotent cells 
and newly differentiated MLCs, gDNA was extracted.  Approximately 5*105 cells 
were collected and gDNA was extracted using the DNeasy Blood & Tissue Kit 
(Qiagen; Hilden, Germany) according to the manufacturer’s protocol.  Clean up 
and concentration of samples was conducted using 100% ethanol and sodium 
acetate.  gDNA samples were resuspended in DNase-free water at concentrations 
of 15-25 ng/µL.  Purity was assessed using a Nanodrop 2000c and deemed 
acceptable with 260/280 ratio’s between 1.8 - 1.9.   
Total cellular RNA was isolated using phenol-chloroform protocol with Tri-
zol™ (Thermo Fisher Scientific).  RNA samples were DNase I (Roche Applied 
Science, Indianapolis, IN) to ensure purity.  Quality and concentration was 
determined with a Nanodrop 2000c.  One µg of each RNA sample was reverse 
transcribed into cDNA using Platinum™ Taq DNA Polymerase High Fidelity Kit 
(Thermo Fisher) according to manufacturer’s instructions.  cDNA samples were 
further diluted to a concentration of 5-10 ng/µL in dnase-free, rnase-free water.   
Gene expression was conducted using TaqMan® Gene Expression Assays 
for APEX1 (Hs00959050_g1), BRCA1 (Hs01556193_m1), RPA1 
(Hs00161419_m1), and RPA3 (Hs01047933_g1); and the endogenous 
housekeeping gene ACTB (Hs99999903_m1).  Real-time quantitative PCR 
experiments were conducted with a StepOnePlus™ Real-Time PCR System 
(Applied Biosystems, Foster City, CA).  TaqMan® Fast Advanced Master Mix (Life 
Technologies) was used as amplification master-mix.  Complete qPCR reactions 
included 1x of TaqMan Fast Master Mix, 50 ng of cDNA template, 1 µL of TaqMan 
Gene Expression Assay (20x), and brought up to 20 µL with water.  Thermal 
cycling conditions were: 1 cycle of 2 minutes at 50°C, 1 cycles of 20 seconds at 
95°C, and 40 cycles of 1 second at 95°C and 20 seconds at 60°C.  All experiments 
were completed in triplicate, with each reaction sub-sampled three times.  Error 
bars represent the standard deviation of three independent experiments 




HTT amplification for fragment analysis  
Using homemade primers (Table 5, Chapter III), we analyzed TNR 
instability using triplet-primed polymerase chain reaction (TP-PCR).  This method 
is previously described in Chapter III, Materials and methods.  Briefly, a forward 
and reverse primer was designed and synthesized targeting the pathogenic 
tandem repeat sequence in the HTT gene, with the forward primer containing a 
bound carboxyfluorescein at its’ 5’ end.  The repetitive (CTG) sequence at the 3’ 
end of the reverse primer allowed for non-specific binding of the primer, while the 
5’ end specificity ensure complete amplification of only the gene specific sequence.  
PCR fragments were subsequently subjected to capillary electrophoresis to 
determine amplicon sizes. 
 
Data analysis and statistical significance 
Gene expression was independently conducted three times with each 
experiment sub-sampled in triplicate.  Raw cycle-threshold (Ct) values of each sub-
sample were averaged to give one mean Ct.  Mean Ct values of tested genes was 
normalized against the housekeeping gene ACTB to determine ΔCt values.  Each 
gene ΔCt value was then normalized to either the wild-type iPSC or MLC line, 
relative to the experiment comparison, to determine ΔΔCt’s.  Fold expression was 
decided by 2-ΔΔCt.  Error bars were determined using the standard deviation of 
experimental triplicate variation between fold-expression.  Data were subjected to 
ANOVA statistical analysis with Dunnett’s test post-hoc to determine statistically 




Successful reprogramming of HD fibroblasts into iPSCs 
 To determine the effects of cellular reprogramming on TNR instability of the 
HTT gene and to measure DNA repair gene expression, we generated iPSCs from 
two HD-affected fibroblast cell lines.  At day 30 after initial reprogramming 
infection, live staining of candidate iPSC colonies was conducted using TRA-1-81.  
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Both HD1 and HD2 cell formations showed positive staining, while iMEF feeder 
cells did not stain (Figs. 26A and 27A).  Morphological similarities of cell colonies 
are see in bright-field images, showing high nuclear-cytoplasm ratios as well as 
defined border formations.  After successful manual splitting, the remainder of 
colonies were analyzed for AP activity.  Again, both HD lines revealed increased 
AP activity, relative to the iMEF feeder layer upon which they were transformed 
(Figs. 26B and 27B).  Gene expression assays revealed that HD1- and HD2-
candidate iPSC lines show significant increases in pluripotency markers (Figs. 26C 
and 27C).  These data confirm successful reprogramming of fibroblast lines into 
induced pluripotent stem cells.   
 
iPSC-HD lines have normalized APEX1, BRCA1, RPA1, and RPA3 gene 
expression 
 We have previously shown that fibroblast lines affected by HD have 
significantly decreased levels of essential DNA damage repair gene expression.  
Our previous work identified APEX1, BRCA1, RPA1, and RPA3 as being down-
regulated in five HD fibroblast lines.  Upon successful reprogramming of HD1 and 
HD2 fibroblast lines into iPSC-HD1 and iPSC-HD2, we conducted qPCR using 
TaqMan Gene Expression Assays to determine whether the DNA repair gene 
deficiency was maintained throughout the reprogramming process.  Analysis of 
these gene expression profiles reveals that iPSC-HD1 and iPSC-HD2 have 
statistically significant up-regulation relative to their native fibroblast expression 
levels (Fig. 28).  Gene expression for APEX1, BRCA1, RPA1, and RPA3 in iPSC-
HD1 showed statistically significant increases between fold changes of ~49 - 86.  
iPSC-HD2 also showed statistically significant increases.  Next we wanted to 
determine if the selected DNA repair gene expression was not only increased 
relative to the native-cell state, but also to determine if gene expression was 
returned to wild-type levels.  Gene expression analysis revealed that iPSC-HD1 
and iPSC-HD2 expressed APEX1, BRCA1, RPA1, and RPA3 at levels consistent 
with two wild-type iPSC lines (iPSC-Wt1 and iPSC-Wt2), with no statistically 
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significant differences (Fig. 29).  These data suggest that the embryonic-like state 













































Fig. 26.  Successful reprogramming of HD1 into induced pluripotent stem cells.  
(A) Cell colonies from the initial reprogramming were stained with TRA-1-81 
live stain to detect pluripotent cells.  Left half of images show phase images of 
morphological colony formation on MEF feeder-layer, while the right half show 
positive TRA-18-1 staining of colonies, but reveal negative binding to the feeder 
layer.  (B) Cell colonies were from the reprogramming plate were positive for 
alkaline phosphatase. (C) Gene expression profile of fibroblast cells lines HD1 
and iPSC-HD1 showing significant increases in pluripotency genes c-Myc, 






Fig. 27.  Successful reprogramming of HD2 into induced pluripotent stem cells. 
(A) Cell colonies from the initial reprogramming were stained with TRA-1-81 
live stain to detect pluripotent cells.  Left half of images show phase images of 
morphological colony formation on MEF feeder-layer, while the right half show 
positive TRA-1-81 staining of colonies, but reveal negative binding to the feeder 
layer. (B) Cell colonies were from the reprogramming plate were positive for 
alkaline phosphatase. (C) Gene expression profile of fibroblast cells lines HD2 
and iPSC-HD2 showing significant increases in pluripotency genes c-Myc, 
















































Fig. 28.  Up-regulation of APEX1, BRCA1, RPA1, and RPA3 in HD-iPSC 
lines.  Analysis of iPSC-HD1 (A) and iPSC-HD2 (B) reveal significant up-
regulation of APEX1, BRCA1, RPA1, and RPA3 relative to their native 
fibroblast cell states.  This reveals epigenetic changes in pluripotency cell 
state could be involved in selected DNA repair gene expression.  Statistical 

















































































Fig. 29.  Gene expression of DNA damage repair genes APEX1, BRCA1, 
RPA1, and RPA3 in two HD-iPSC lines.  Analysis of selected DNA damage 
repair genes in two HD-derived iPSC (iPSC-HD1 and iPSC-HD2) lines reveals 
similar expression levels relative to two wild-type iPSC (iPSC-Wt1 and iPSC-
Wt2) lines.  This indicates that reprogramming to pluripotent cell states, and the 











































MLC-HD lines exhibit decreases in BRCA1, RPA1, and RPA3 expression 
 To investigate whether targeted differentiation of iPSC-HD lines retained 
normalized DNA repair gene expression, we differentiated these lines to MLCs.  
After 10 population doublings, mRNA was analyzed to determine gene expression 
of APEX1, BRCA1, RPA1, and RPA3. Interestingly, both MLC-HD1 and MLC-HD2 
did not show changes in APEX1 expression (Fig. 30). The expression of RPA1 
showed a significant decrease in MLC-HD1, but a non-significant decrease in 
MLC-HD2.  Further, MLC-HD1 showed decreased levels of BRCA1 and RPA3.  
The maintained regulation of APEX1 infers that the deficiency-causing mechanism 
was no longer present in MLC-HD lines.  The return to decreased levels of BRCA1, 
RPA1, and RPA3 suggests that the mechanism causing the gene dysfunction 
























Fig. 30.  Differentiation into MLC’s reveals down-regulation of BRCA1, RPA1, 
and RPA3.  Targeted differentiation of HD-iPSC lines into mesenchymal-like-
cells (MLCs) reveals DNA repair gene expression of BRCA1, RPA1, and RPA3 
starts to decrease in MLC-HD1 and MLC-HD2 cells lines, indicating epigenetic 
















































Contraction-biased TNR instability in iPSC-HD lines 
 Genomic DNA samples of iPSC-HD1 and iPSC-HD2 were taken 
periodically during routine culturing.  Approximately one sixth (~5*104 cells) of the 
entire population of “passaging cells” was removed for gDNA extraction and 
subsequent TNR instability characterization.  To determine the rate of TNR 
instability, we collected gDNA samples at every passage up to passage 10.  Using 
TP-PCR and capillary electrophoresis, we witnessed contraction-biased TNR 
instability within the pathogenic region of the HTT gene in both iPSC-HD lines.  
Characterization of iPSC-HD1 at passage 1 shows the HD-pathogenic allele 
containing (CAG) repeats of predominantly 44, with the unaffected allele having 
18.  After 8 population doublings, iPSC-HD1 shows a contraction of the affected 
allele to 43 (CAG)’s (Fig. 31).  This contraction in iPSC-HD1 remained stable 
through more than 10 passages.  Interestingly, iPSC-HD2 showed an identical 
pattern of contraction and subsequent stability, where it began at 42 (CAG)’s and 
contracted to 41 at passage 8 (Fig. 32).  Furthermore, the affected allele remained 
stable for the continuation of the experiment, after the initial contraction.  However, 
we also witnessed that both iPSC-HD lines exhibited slight contractions in the 
unaffected alleles, where iPSC-HD1 contracted from (CAG) repeats of 18 to 17 
(Fig. 33), and iPSC-HD2 contracted from 17 to 16 (CAG) repeats (Fig. 34).  To the 























iPSC-HD1 Affected Allele 
Fig. 31.  Capillary electrophoresis fragment analysis reveals contraction-biased 























Fig. 31.  Continued.  Genomic DNA samples extracted from iPSC-HD1 were 
characterized for TNR instability in the HTT pathogenic region.  Samples were 
taken at passages 1, 3, 4, and 10.  Over the course of 10 passages, both cell 
lines revealed contractions of the TNR region.  iPSC-HD1 affected allele shows 
a decrease from 44 to 43.  Interestingly, both cells lines maintained the 












iPSC-HD2 Affected Allele 
Fig. 32.  Capillary electrophoresis fragment analysis reveals contraction-


























Fig. 32.  Continued.  Genomic DNA samples extracted from iPSC-HD2 were 
characterized for TNR instability in the HTT pathogenic region.  Samples were 
taken at passages 1, 3, 4, and 10.  Over the course of 10 passages, both cell 
lines revealed contractions of the TNR region.  iPSC-HD2 shows a decrease 
from 42 to 41.  Interestingly, both cells lines maintained the contracted allele 









Fig. 33.  Fragment analysis reveals contraction-biased TNR instability in both 
alleles of iPSC-HD1.  Genomic DNA samples extracted from iPSC-HD1 were 
characterized for TNR instability in the HTT pathogenic region.  Samples were 
taken at passages 1, 3, 4, and 10.  As well as the reported contraction of the 
HD-affected allele, here we see the unaffected allele contract from 18 to 17 

















Fig. 34.  Fragment analysis reveals contraction-biased TNR instability in both 
alleles of iPSC-HD2.  Genomic DNA samples extracted from iPSC-HD2 were 
characterized for TNR instability in the HTT pathogenic region.  Samples were 
taken at passages 1, 3, 4, and 10.  Here we see the unaffected allele contract 











HTT gene TNR stability in iPSC-HD derived MLCs 
 To determine whether TNR stability was maintained in iPSC-HD derived 
cells, we further differentiated each line into MLCs.  Genomic DNA was collected 
from newly differentiated MLC-HD lines at passage 1 (start of differentiation), and 
every passage up to 10.  Using TP-PCR and capillary electrophoresis fragment 
analysis, we characterized the (CAG) repeat length of the HTT gene pathogenic 
region in MLC-HD1 and MLC-HD2.  Both newly created MLC lines showed the 
same repeat expansions in both alleles, relative to their starting HTT gene 
expansions from their native iPSC state.  MLC-HD1 started at 17/43 (CAG) repeats 
and maintained those repeats for 10 population doublings (Fig. 35).  MLC-HD2 
started at 16/41 (CAG) repeats, and ended at the same sizes after 10 population 
doublings (Fig. 36).  These data infer that differentiation of HD cells from 
pluripotency to mesodermal lineage does not have destabilizing effects on the TNR 
region in HD, as we did not witness expansions or contractions in the entire 
population of MLC cells.  As well, we also conclude that cell reprogramming, and 


























Fig. 35.  Capillary electrophoresis fragment analysis reveals TNR stability in 
mesenchymal-like cells differentiated from iPSC-HD1.  Characterization of 
HTT pathogenic region reveals that the (CAG) expansions did not show 
instability from the differentiation process or through 10 population doublings.  
MLC-HD1 started with, and maintained 17/43 (CAG) repeats in both alleles.   


















Fig. 36.  Capillary electrophoresis fragment analysis reveals TNR stability in 
mesenchymal-like cells differentiated from iPSC-HD2. Characterization of 
HTT pathogenic region reveals that the (CAG) expansions did not show 
instability from the differentiation process or through 10 population doublings.  
MLC-HD2 started with, and maintained 16/41 (CAG) repeats in both alleles.   












 We previously reported that HD-affected fibroblast cell lines exhibit 
decreased expression of DNA repair genes that have been shown to be effectors 
of TNR instability.  We also reported that treatment of HD-fibroblasts with a 
hypomethylation agent resulted in up-regulation of gene expression, and that 
intermittent treatment for prolonged periods induced TNR stability, preventing 
(CAG) expansions.  In this study, we wanted to investigate whether the gross 
epigenetic changes seen during the reprogramming to pluripotency had an effect 
on DNA repair gene expression in HD (Carey et al., 2011; Hewitt et al., 2011; 
Leung et al., 2014; Vaskova et al., 2013).  Further, we wanted to determine 
whether mechanisms associated with cellular reprogramming and subsequent 
differentiation affected TNR stability of the HTT gene.  Here we report that 
reprogramming terminally differentiated HD fibroblasts into iPSC resulted in up-
regulation of DNA repair genes APEX1, BRCA1, RPA1, and RPA3.  Our results 
agree with other studies showing that iPSCs have differentially expressed genes, 
and some showing enhanced regulation of DNA repair gene expression (Cai et al., 
2015; Fan et al., 2011).  Importantly, we show that during pluripotency, early 
passaged HD-affected cells undergo contraction-biased instability of the affected 
gene.  Late passage HD-iPSC lines show no changes in TNR regions, thus 
implying increased stability.  Interestingly, these results contrast with data shown 
in Friedreich ataxia (FRDA) iPSCs, another neurodegenerative disease caused by 
TNR expansions (Du et al., 2012).  Though HD and FRDA are both genetic 
diseases caused by TNR expansions, they differ in tandem repeat sequences, 
where repeats in HD consist of (CAG) and FRDA consist of (GAA).  The different 
nucleotide sequence of HD and FRDA, create different mutant products, and these 
data together suggest that the mutant products are misbehaving in different 
fashions during pluripotency.  The subsequent differentiation of HD-iPSC lines into 
MLCs revealed that gene expression of BRCA1, RPA1, and RPA3 begin to regress 
to initial down-regulated levels, as shown in our previous work.  However, even 
though regulation of these genes show decreases, the expression levels remain 
above expression levels seen in their parental cell-state.  This response to 
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differentiation suggests that re-installed epigenetic patterning is affecting gene 
expression.  Also, HD-MLCs reveal that HTT gene sizes of the pathogenic regions 
remained static through 10 passages.    While no mechanism of TNR instability 
has been comprehensively defined in HD, these data suggest that mechanisms 
associated with pluripotency and early-differentiated cells act protectively on the 
TNR region of the HTT gene.   
Changes associated with reprogramming terminally differentiated cells into 
a pluripotent cell-state is extensive.  Our observations of differential gene 
expression of DNA repair genes in HD-iPSC lines confirm other reports of altered 
cell regulatory processes in conjunction with pluripotency.  HD-iPSC models have 
been reported to show similar phenotypic repeat expansions during 
reprogramming relative to native-state cells used for reprogramming, but it is yet 
to be reported whether the rate of TNR instability is altered or enhanced during 
pluripotency (Consortium, 2012).  These findings suggest that DNA repair gene 
up-regulation assist in the maintenance of genome fidelity and that subsequent 
differentiation maintains repair gene expression briefly, possibly inducing genomic 
TNR stability.  Our observations indicate that dysfunction DNA repair gene 
regulation in somatic cells affected by HD is a consequence of epigenetic 
patterning in HD.  Importantly, we show that reprogramming of DNA repair deficient 
cells rescues gene expression to wild-type levels.  Our data reveal that pathogenic 
TNR regions of the toxic HTT gene are somehow protected from expansion-biased 
instability during pluripotency, as evidenced by the contraction-only changes in 
early passages, as well as the static repeat length in late passages.  Furthermore, 
the protective properties elicited upon the TNR region seem to be retained with 












Identifying the mechanism of TNR instability in HD is essential to establish 
targeted therapeutic treatments to eradicate HD.  The collective findings in this 
work are compelling as they provide the first evidence that mitotically active cells 
affected by HD have decreased expression of DNA damage repair genes essential 
to genome integrity and TNR stability.  Our hypothesis that mHtt protein in 
fibroblasts affects DNA repair gene expression was supported by our findings.  
First, we determined that multiple genes associated with DNA damage repair are 
differentially expressed in multiple HD cell samples.  We then determined that 
treatment with the hypomethylating agent 5-azacytidine resulted in DNA repair 
gene up-regulation, as well as inducing TNR stability in multiple HD fibroblast 
samples.  Further, we revealed that reprogramming of HD-fibroblast cells into 
induced-pluripotent stem cells resulted in up-regulation of select DNA repair gene 
expression to wild-type expression levels, and contraction-biased TNR instability.  
Also, we show that HD-iPSCs that undergo differentiation into MLCs retain their 
starting allele lengths, and they retain wild-type expression levels of APEX1, a 
protein essential for neuronal survivability.  Importantly, HD-MLC lines showed 
enhanced TNR stability.  We determined that epigenetic changes in the genome 
of HD cells determined DNA repair gene expression and effected TNR stability.  
These results will have clinical and research relevance for HD on multiple 
platforms.  First, the identification of endogenously deficient DNA damage repair 
genes provides possible biomarkers to monitor disease progression and 
therapeutic treatments.  This will also provide researchers insight into possible 
cellular machinery that is absent in HD, thus elucidating to possible dysfunctional 
repair mechanisms.  Data showing differential methylation patterning in HD-
affected fibroblasts also reveals the extent to which mHtt interacts and interrupts 
normal cellular processes.  As well, identification of 5-azacytidine as a TNR 
stabilizing agent has promising implications as a pharmacological agent that 
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prevents somatic TNR mosaicism, possibly reducing the severity of disease 
progression over time.    Furthermore, the initial contraction-biased instability in 
conjunction with pluripotency, and the subsequent induced stability from 
pluripotency to differentiated MLCs suggests that a mechanism associated with 
reprogramming is activated and is initially maintained in early passages.  Future 
identification of the mechanism involved in this finding will elucidate 
pharmacological targets for HD treatments. 
Although our study has identified a number of DNA repair genes down-
regulated in HD, substantial data were found that present new avenues of 
discovery.  Each finding we report here only exponentially increases the number 
of questions to be asked.  After this work, the next steps are to create striatal 
neurons from Wt-iPSC and HD-iPSC and (1) investigate the extent of the DNA 
repair deficiency, (2) measure selected DNA repair expression response after 5-
azacytidine treatments, and (3) measure TNR instability over prolonged culture.  I 
speculate that similar DNA repair gene deficiencies will be present, thus narrowing 
the focus of targets causing TNR instability in striatal neurons.  Further, our data 
that shows APEX1 up-regulation in response to 5-azacytidine implies that adjusted 
treatments might improve the overall survivability of diseased neurons.   
Collectively these finding provide insight into the spontaneous (CAG) 
expansions with the pathogenic region of the HTT gene.  Further, this work 
promotes the continued investigation of DNA repair gene expression and HD-
iPSC, for use as cell models to determine comprehensive mechanisms involved in 
TNR instability.  Together these data emphasize the complexity of mechanisms 
involved in TNR somatic mosaicism experienced in HD.  Consequently, additional 
studies must be conducted involving iPSC-derived cells to fully understand TNR 
instability.  However, we have identified that pathways and mechanisms related to 
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